Unnamed: 0,title,date,stock,sentiment
659629.0,"The Daily Biotech Pulse: Keytruda Setback For Merck, Denali Pulls The Plug On Neurological Asset",2020-06-10 07:30:00-04:00,ILMN,positive
659630.0,Illumina Receives First FDA Emergency Use Authorization for a Sequencing-Based COVID-19 Diagnostic Test,2020-06-10 06:16:00-04:00,ILMN,negative
659631.0,"Ginkgo Bioworks Reports $70M Investment From Illumina, Existing Co. Investors General Atlantic, Viking Global",2020-05-28 06:09:00-04:00,ILMN,neutral
659632.0,"Shares of several healthcare companies are trading higher in sympathy with the overall market amid strength in oil, strong earnings from Lowe's and optimism towards a US economic rebound.",2020-05-20 11:19:00-04:00,ILMN,positive
659633.0,Shares of several healthcare companies are trading higher in sympathy with the overall market as optimism around a coronavirus vaccine increased following news from Moderna.,2020-05-18 10:23:00-04:00,ILMN,positive
659634.0,"The Daily Biotech Pulse: ASCO Abstracts Create Stock Ripples, Applied DNA's Coronavirus Test Receives EUA, Biopharmx Shareholders Vet Reverse Merger",2020-05-14 08:32:00-04:00,ILMN,positive
659635.0,Illumina Appoints Alex Aravanis As Chief Technology  Officer & Appoints Mostafa Ronaghi To Lead Entrepreneurial Development,2020-05-04 16:32:00-04:00,ILMN,neutral
659636.0,Shares of several healthcare companies are trading lower as markets dip following recent strength. Markets have sold off as investors weigh recent earnings and amid concerns of renewed US-China trade frictions.,2020-05-01 12:35:00-04:00,ILMN,positive
659637.0,"Wells Fargo Maintains Underweight on Illumina, Raises Price Target to $290",2020-05-01 10:05:00-04:00,ILMN,positive
659638.0,"Stifel Maintains Buy on Illumina, Raises Price Target to $325",2020-05-01 08:42:00-04:00,ILMN,neutral
659639.0,"Illumina Q1 Adj. EPS $1.640 Beats $1.250 Estimate, Sales $859.000M Beat $853.610M Estimate",2020-04-30 16:18:00-04:00,ILMN,neutral
659640.0,"The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Hologic To Launch Coronavirus Test, Amarin's Strong Q1",2020-04-30 07:19:00-04:00,ILMN,positive
659641.0,"Earnings Scheduled For April 30, 2020",2020-04-30 04:16:00-04:00,ILMN,neutral
659642.0,"Illumina Reports Receives $1.4M Donation For Its Sequencing Systems, Related Consumables Intended To Expand Coroanvirus Sequencing CApabilities, Capacity In 10 African Countries",2020-04-28 09:07:00-04:00,ILMN,positive
659643.0,"The Week Ahead In Biotech (April 26-May 2): Cancer Conference, Earnings News Flow In The Spotlight",2020-04-26 16:37:00-04:00,ILMN,negative
659644.0,"Benzinga's Top Upgrades, Downgrades For April 24, 2020",2020-04-24 09:38:00-04:00,ILMN,positive
659645.0,"Citigroup Downgrades Illumina to Neutral, Raises Price Target to $320",2020-04-24 07:40:00-04:00,ILMN,neutral
659646.0,"Benzinga's Top Upgrades, Downgrades For April 21, 2020",2020-04-21 09:35:00-04:00,ILMN,positive
659647.0,Illumina shares are trading lower after Baird downgraded the stock from Outperform to Neutral and announced a price target of $310 per share.,2020-04-21 09:11:00-04:00,ILMN,positive
659648.0,"Baird Downgrades Illumina to Neutral, Announces $310 Price Target",2020-04-21 06:50:00-04:00,ILMN,neutral
659649.0,"Baird Maintains Outperform on Illumina, Lowers Price Target to $310",2020-04-15 11:55:00-04:00,ILMN,negative
659650.0,Illumina shares are trading lower after the company reported Q1 earnings. The company also withdrew its FY20 EPS and sales guidance.,2020-04-15 10:16:00-04:00,ILMN,neutral
659651.0,Illumina To Withdraw Full-Year FY20 Sales And EPS Guidance,2020-04-14 16:08:00-04:00,ILMN,neutral
659652.0,Illumina Sees Q1 Sales ~$858M Vs. $830.01M Estimate,2020-04-14 16:06:00-04:00,ILMN,neutral
659653.0,Shares of several healthcare companies are trading higher as markets gain amid optimism that coronavirus cases in several US hotspots may be peaking. A sooner peak could mean a sooner return to economic activity.,2020-04-06 09:42:00-04:00,ILMN,positive
659654.0,"Stifel Maintains Buy on Illumina, Lowers Price Target to $298",2020-04-02 11:25:00-04:00,ILMN,negative
659655.0,"Wells Fargo Maintains Underweight on Illumina, Lowers Price Target to $245",2020-03-30 12:16:00-04:00,ILMN,positive
659656.0,"Shares of several healthcare companies are trading lower, selling off from this week's strength. While the US stimulus package boosted economic optimism, demand concerns still exist amid the coronavirus outbreak.",2020-03-27 10:58:00-04:00,ILMN,positive
659657.0,"Shares of several healthcare companies are trading higher following Senate passage of a $2 trillion economic stimulus package, which has lifted stocks across sectors.",2020-03-26 11:49:00-04:00,ILMN,positive
659658.0,"Barclays Maintains Overweight on Illumina, Lowers Price Target to $350",2020-03-26 10:51:00-04:00,ILMN,negative
659659.0,"Citigroup Maintains Buy on Illumina, Lowers Price Target to $250",2020-03-20 09:29:00-04:00,ILMN,negative
659660.0,"The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection",2020-03-19 07:37:00-04:00,ILMN,neutral
659661.0,Shares of several healthcare companies are trading lower in sympathy with the overall market on continued downward momentum caused by the coronavirus. The virus has had a negative impact on the global economy.,2020-03-16 09:40:00-04:00,ILMN,negative
659662.0,Shares of several healthcare companies are trading higher as the market rebounds following Thursday's selloff. NOTE: Since the coronavirus outbreak the healthcare sector has been extremely volatile.,2020-03-13 09:29:00-04:00,ILMN,positive
659663.0,Stocks That Hit 52-Week Lows On Thursday,2020-03-12 12:10:00-04:00,ILMN,negative
659664.0,"The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO",2020-03-12 07:37:00-04:00,ILMN,negative
659665.0,Stocks That Hit 52-Week Lows On Friday,2020-02-28 10:16:00-05:00,ILMN,negative
659666.0,Shares of several healthcare companies are trading lower as the global coronavirus spread continues to cause equities across sectors to sell off amid worsened economic outlook.,2020-02-28 09:06:00-05:00,ILMN,negative
659667.0,"The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO",2020-02-28 07:28:00-05:00,ILMN,neutral
659668.0,Stocks That Hit 52-Week Lows On Thursday,2020-02-27 10:23:00-05:00,ILMN,negative
659669.0,Shares of several healthcare companies are trading lower as growing coronavirus fears hamper economic outlook.,2020-02-27 09:28:00-05:00,ILMN,negative
659670.0,Shares of several healthcare and biotech companies are trading lower amid continued spread of coronavirus including notable upticks in Iran and Italy. NOTE: The virus has raised fear of a global economic slowdown.,2020-02-24 08:37:00-05:00,ILMN,negative
659671.0,Illumina shares are trading higher after the company's 13G showed that Oarsman Capital increased its stake in the company.,2020-02-14 15:23:00-05:00,ILMN,positive
659672.0,Illumina shares are trading lower despite beating Q4 EPS and sales estimates. The company also issued FY20 EPS guidance. Analysts at Wells Fargo and Citigroup both lowered their price targets on the stock following earnings.,2020-01-30 11:23:00-05:00,ILMN,positive
659673.0,"The Daily Biotech Pulse: Sanofi Reports Positive Readout, Tonix Vaccine Candidate Aces Animal Study, Hologix's Weak Guidance",2020-01-30 09:26:00-05:00,ILMN,positive
659674.0,10 Biggest Price Target Changes For Thursday,2020-01-30 08:45:00-05:00,ILMN,neutral
659675.0,"Wells Fargo Maintains Underweight on Illumina, Lowers Price Target to $290",2020-01-30 08:23:00-05:00,ILMN,positive
659676.0,"Citigroup Maintains Buy on Illumina, Lowers Price Target to $350",2020-01-30 07:26:00-05:00,ILMN,negative
659677.0,Illumina Sees FY20 Adj. EPS $6.80-$7.00 vs $6.91 Est.,2020-01-29 16:08:00-05:00,ILMN,neutral
659678.0,"Illumina Q4 EPS $1.7 Beats $1.58 Estimate, Sales $953M Beat $941.1M Estimate",2020-01-29 16:07:00-05:00,ILMN,neutral
659679.0,"The Daily Biotech Pulse: Novartis Earnings, Hepion's NASH Candidate Beats Rival Drugs, Annovis Bio To Debut",2020-01-29 08:30:00-05:00,ILMN,neutral
659680.0,"Earnings Scheduled For January 29, 2020",2020-01-29 04:06:00-05:00,ILMN,neutral
659681.0,"The Week Ahead In Biotech: Amgen, Eli Lilly, Pfizer In Earnings Mix, IPO Flow Resumes",2020-01-26 10:23:00-05:00,ILMN,neutral
659682.0,Illumina Sees High Teens Growth In China With Roche's Strong Footprint In China,2020-01-13 12:29:00-05:00,ILMN,positive
659683.0,Illumina And Roche Partner To Broaden Patient Access To Genomic Testing,2020-01-13 11:56:00-05:00,ILMN,neutral
659684.0,Illumina Inc Says NovaSeq Shipments Are Expected To Be Lower Than 2019,2020-01-13 11:55:00-05:00,ILMN,negative
659685.0,Illumina Sees 2020 Non-GAAP EPS $6.80-$7.00,2020-01-13 11:41:00-05:00,ILMN,neutral
659686.0,Illumina Expects 9%-11% Revenue Growth In 2020; Expects Sequencing To Grow 14% In 2020,2020-01-13 11:39:00-05:00,ILMN,positive
659687.0,Illumina Shares Dip ~5.5% As Co. Presents At JP Morgan Healthcare Conference,2020-01-13 11:35:00-05:00,ILMN,positive
659688.0,Illumina Files Patent Infringement Suits Against BGI In Sweden And United Kingdom,2020-01-10 09:07:00-05:00,ILMN,negative
659689.0,ArcherDX And Illumina Announce Partnership To Co-Market Portfolio Of ArcherDX In-Vitro Diagnostic Tests,2020-01-10 08:12:00-05:00,ILMN,neutral
659690.0,"Piper Sandler Maintains Overweight on Illumina, Raises Price Target to $370",2020-01-09 11:48:00-05:00,ILMN,negative
659691.0,"Benzinga's Top Upgrades, Downgrades For January 8, 2020",2020-01-08 10:56:00-05:00,ILMN,positive
659692.0,"Wells Fargo Initiates Coverage On Illumina with Underweight Rating, Announces $300 Price Target",2020-01-08 09:12:00-05:00,ILMN,positive
659693.0,"Citigroup Initiates Coverage On Illumina with Buy Rating, Announces $385 Price Target",2020-01-07 07:03:00-05:00,ILMN,neutral
659694.0,"Benzinga's Top Upgrades, Downgrades For January 3, 2020",2020-01-03 11:33:00-05:00,ILMN,positive
659695.0,"The Daily Biotech Pulse: Acorda Surges As Point72 Hikes Stake, Novan Sinks On Failed Study, Illumina-Pac Bio Terminate Merger",2020-01-03 07:55:00-05:00,ILMN,negative
659696.0,Illumina and Pacific Biosciences Announce Termination of Merger Agreement; Illumina To Pay Pacific $98M Termination Fee,2020-01-02 16:06:00-05:00,ILMN,positive
659697.0,"Evercore ISI Group Downgrades Illumina to In-Line, Announces $340 Price Target",2020-01-02 07:22:00-05:00,ILMN,neutral
659698.0,"Illumina  Exercised Its Right To Extend The End Time Of The Agreement & Plan Of Merger With Pacific Biosciences To March 31, 2020",2019-12-18 16:25:00-05:00,ILMN,positive
659699.0,"Natera Shares Down 4.4% For Session But Quiet Here As Traders Circulate Word IPR Patent Trial Against Co.'s '592 Patent By Illumina Was Instituted By Patent Trial, Appeal Board",2019-12-18 11:23:00-05:00,ILMN,positive
659700.0,"Cowen & Co. Maintains Outperform on Illumina, Raises Price Target to $335",2019-12-18 08:32:00-05:00,ILMN,neutral
659701.0,"The Daily Biotech Pulse: Positive Adcom Verdict For Merck, Homology Medicine Slips On Mixed Gene Therapy Efficacy Data",2019-12-18 07:23:00-05:00,ILMN,positive
659702.0,ArcherDX Announces Partnership with Illumina to Develop In-Vitro Diagnostic Tests,2019-12-03 08:10:00-05:00,ILMN,neutral
659703.0,"Benzinga's Top Upgrades, Downgrades For November 15, 2019",2019-11-15 09:59:00-05:00,ILMN,positive
659704.0,"Stifel Nicolaus Initiates Coverage On Illumina with Buy Rating, Announces $345 Price Target",2019-11-15 06:32:00-05:00,ILMN,neutral
659705.0,"Cramer Weighs In On Nike, Beyond Meat And More",2019-11-09 16:18:00-05:00,ILMN,neutral
659706.0,Lexent Bio And Illumina Enter Partnership To Develop An In Vitro Diagnostic Kit,2019-11-08 09:02:00-05:00,ILMN,neutral
659707.0,Illumina shares are trading higher potentially on a rebound after the stock fell approximately 9% following Q3 earnings.,2019-10-28 10:54:00-04:00,ILMN,positive
659708.0,"Benzinga's Top Upgrades, Downgrades For October 25, 2019",2019-10-25 12:44:00-04:00,ILMN,positive
659709.0,"Canaccord Genuity Maintains Hold on Illumina, Raises Price Target to $310",2019-10-25 10:14:00-04:00,ILMN,neutral
659710.0,"Piper Jaffray Maintains Overweight on Illumina, Lowers Price Target to $341",2019-10-25 10:10:00-04:00,ILMN,negative
659711.0,﻿Illumina shares are trading lower despite the company reporting better-than-expected Q3 EPS and sales results and the company also issued FY19 EPS guidance above analyst estimates.,2019-10-25 09:06:00-04:00,ILMN,neutral
659712.0,"Guggenheim Initiates Coverage On Illumina with Buy Rating, Announces $350 Price Target",2019-10-25 07:20:00-04:00,ILMN,neutral
659713.0,"The Daily Biotech Pulse: Melinta Crosses FDA Hurdle But Sees Liquidity Pushback, Positive Readout For Aclaris Wart Drug",2019-10-25 07:12:00-04:00,ILMN,positive
659714.0,Illumina shares are trading lower despite the company reporting better-than-expected Q3 EPS and sales results and the company also issued FY19 EPS guidance above analyst estimates,2019-10-24 16:43:00-04:00,ILMN,neutral
659715.0,5 Stocks Moving In Thursday's After-Hours Session,2019-10-24 16:36:00-04:00,ILMN,neutral
659716.0,Illumina Sees FY19 Adj. EPS $6.40-$6.45 vs $6.04 Est.,2019-10-24 16:08:00-04:00,ILMN,neutral
659717.0,"Illumina Q3 Adj. EPS $1.93 Beats $1.4 Estimate, Sales $907M Beat $870.84M Estimate",2019-10-24 16:07:00-04:00,ILMN,neutral
659718.0,21 Stocks Moving In Thursday's Mid-Day Session,2019-10-24 13:21:00-04:00,ILMN,neutral
659719.0,"The Daily Biotech Pulse: Acorda To Trim Jobs, GlaxoSmithKline Gets FDA Nod, Edward Lifesciences Posts Q3 Beat-And-Raise",2019-10-24 07:36:00-04:00,ILMN,neutral
659720.0,"The Week Ahead In Biotech: Earnings Trickle In, While Glaxo, Melinta, Foamix And Eton Await FDA Verdict",2019-10-20 08:08:00-04:00,ILMN,positive
659721.0,Shares of several healthcare companies are trading higher after President Trump made positive remarks on the U.S.-China trade talks as traders grew more optimistic over the possibility of a limited trade deal. Trump is scheduled to meet with Chinese Vice Premier Liu He at the White House today.,2019-10-11 11:19:00-04:00,ILMN,positive
659722.0,Shares of several healthcare companies are trading higher after multiple reports suggesting China is open to a partial trade deal surfaced. The reports renewed optimism in the upcoming U.S.-China trade talks.,2019-10-09 11:10:00-04:00,ILMN,positive
659723.0,Shares of several healthcare companies are trading lower with the broader market after the US expanded its trade blacklist to include China's top AI firms. The US also will increase its tariffs on $250 billion worth of goods from 25% to 30% on Oct 15.,2019-10-08 10:36:00-04:00,ILMN,positive
659724.0,"Qiagen Shares Tumble Following Q3 Sales Warning, Sudden CEO Departure",2019-10-08 09:45:00-04:00,ILMN,negative
659725.0,"The Daily Biotech Pulse: D-Day For Clinuvel, Qiagen Warns Of Q3 Shortfall, Prevail Announces Gene Therapy Collaboration",2019-10-08 07:11:00-04:00,ILMN,negative
659726.0,"'Fast Money Halftime Report' Traders Advise Their Viewers On Motorola, Alibaba And More",2019-10-03 17:22:00-04:00,ILMN,neutral
659727.0,Illumina Shares Unaffected Amid Headline GMI Has Again Sued Co. For Patent Infringement,2019-10-02 10:58:00-04:00,ILMN,negative
659728.0,Shares of several healthcare companies are trading lower in sympathy with the overall market on continued fears of a recession amid a weak ADP jobs report. There is also uncertainty in the market over the upcoming U.S.-China meeting next week.,2019-10-02 10:33:00-04:00,ILMN,negative
659729.0,"Shares of several healthcare companies are trading lower, potentially on recent Democratic primary polls showing Senator Elizabeth Warren in the lead.",2019-09-26 12:43:00-04:00,ILMN,neutral
659730.0,"UPDATE: Argus Maintains Buy On Illumina, Raises Target To $340 As Firm Notes 'we expect that many of the issues facing Illumina will be temporary and look for a return to double-digit earnings growth in 2020'",2019-09-25 11:10:00-04:00,ILMN,positive
659731.0,"Argus Research Maintains Buy on Illumina, Raises Price Target to $340",2019-09-25 08:30:00-04:00,ILMN,neutral
659732.0,Shares of many pharma/therapeutics stocks trading lower in sympathy with overall market weakness. Reports China is planning to cut prices for widely-used drugs may also be pressuring the sector today.,2019-09-24 14:01:00-04:00,ILMN,negative
659733.0,"CVS, Shake Shack And More 'Fast Money Halftime Report' Picks From September 12",2019-09-12 16:10:00-04:00,ILMN,negative
659734.0,﻿Illumina shares are trading higher after on seemingly no company-specific news. The stock looks to be continuing to rebounding from the 52-week low level of $264.56 from earlier in the week.,2019-09-12 14:58:00-04:00,ILMN,negative
659735.0,Illumina shares are trading higher after on seemingly no company-specific news. The stock looks to be continuing to rebounding from the 52-week low level of $264.56,2019-09-11 10:07:00-04:00,ILMN,negative
659736.0,Illumina shares are trading higher after on seemingly no company-specific news. The stock looks to be rebounding from the 52-week low level of $264.56,2019-09-10 14:30:00-04:00,ILMN,negative
659737.0,"The Daily Biotech Pulse: Translate Bio Halts mRNA Therapy Trial, Roche Multiple Sclerosis Biomarker Data, D-Day For Xeris",2019-09-10 07:36:00-04:00,ILMN,neutral
659738.0,"Illumina Option Alert: Jun, 2021 $260 Calls at the Ask: 785 @ $60.701 vs 4 OI; Earnings 10/22 After Close [est] Ref=$271.19",2019-09-06 12:56:00-04:00,ILMN,positive
659739.0,Stocks That Hit 52-Week Lows On Wednesday,2019-09-04 11:39:00-04:00,ILMN,negative
659740.0,"Benzinga's Top Upgrades, Downgrades For July 30, 2019",2019-07-30 09:59:00-04:00,ILMN,positive
659741.0,"UBS Maintains Buy on Illumina, Raises Price Target to $355",2019-07-30 09:40:00-04:00,ILMN,neutral
659742.0,33 Healthcare Stocks Moving In Today's Pre-Market Session,2019-07-30 09:16:00-04:00,ILMN,neutral
659743.0,10 Biggest Price Target Changes For Tuesday,2019-07-30 09:13:00-04:00,ILMN,neutral
659744.0,Illumina shares are trading lower after the company reported worse-than-expected Q2 sales results. The company also issued FY19 EPS guidance below analyst estimates.,2019-07-30 08:59:00-04:00,ILMN,neutral
659745.0,"Piper Jaffray Maintains Overweight on Illumina, Lowers Price Target to $348",2019-07-30 08:32:00-04:00,ILMN,negative
659746.0,"Canaccord Genuity Downgrades Illumina to Hold, Lowers Price Target to $300",2019-07-30 07:40:00-04:00,ILMN,negative
659747.0,45 Healthcare Stocks Moving In Monday's After-Market Session,2019-07-30 04:54:00-04:00,ILMN,neutral
659748.0,Illumina shares are trading lower after the company reported worse-than-expected Q2 sales results. The company also issued FY19 EPS guidance below analyst estimates.,2019-07-29 16:18:00-04:00,ILMN,neutral
659749.0,Illumina Sees FY19 Adj. EPS $6-$6.10 vs $6.38 Estimate,2019-07-29 16:15:00-04:00,ILMN,neutral
659750.0,"Illumina Q2 EPS $1.35 Beats $1.34 Estimate, Sales $838M Miss $866.16M Estimate",2019-07-29 16:14:00-04:00,ILMN,negative
659751.0,Q2 Earnings Preview For Illumina,2019-07-29 07:27:00-04:00,ILMN,neutral
659752.0,"Earnings Scheduled For July 29, 2019",2019-07-29 04:52:00-04:00,ILMN,neutral
659753.0,40 Biggest Movers From Friday,2019-07-15 05:47:00-04:00,ILMN,neutral
659754.0,Mid-Afternoon Market Update: Illumina Drops On Guidance Warning; Milacron Holdings Shares Jump,2019-07-12 14:35:00-04:00,ILMN,negative
659755.0,36 Stocks Moving In Friday's Mid-Day Session,2019-07-12 12:38:00-04:00,ILMN,neutral
659756.0,Mid-Day Market Update: Tower International Jumps Following Acquisition News; US Xpress Shares Plunge,2019-07-12 12:34:00-04:00,ILMN,positive
659757.0,BofA Double Downgrades Illumina After Thursday's 'Big Miss',2019-07-12 10:45:00-04:00,ILMN,negative
659758.0,What Caused The Opening Gap In Illumina?,2019-07-12 10:32:00-04:00,ILMN,neutral
659759.0,Mid-Morning Market Update: Markets Open Higher; Infosys Raises FY Forecast,2019-07-12 10:29:00-04:00,ILMN,neutral
659760.0,"Deutsche Bank Maintains Hold on Illumina, Lowers Price Target to $280",2019-07-12 09:28:00-04:00,ILMN,negative
659761.0,"Benzinga's Top Upgrades, Downgrades For July 12, 2019",2019-07-12 08:55:00-04:00,ILMN,positive
659762.0,Illumina Shares Slammed On Guidance Warning,2019-07-12 08:17:00-04:00,ILMN,negative
659763.0,28 Stocks Moving In Friday's Pre-Market Session,2019-07-12 08:15:00-04:00,ILMN,neutral
659764.0,Illumina Inc shares are trading lower after the company reported preliminary Q2 sales below analyst estimates.,2019-07-12 07:32:00-04:00,ILMN,neutral
659765.0,"The Daily Biotech Pulse: Hookipa Leaps, Illumina Dims On Q2 Warning, Novartis-Amgen Halt Alzheimer's Study",2019-07-12 07:24:00-04:00,ILMN,negative
659766.0,Bank of America Downgrades Illumina to Underperform,2019-07-12 07:22:00-04:00,ILMN,neutral
659767.0,A Peek Into The Markets: US Stock Futures Up Ahead Of Producer Price Index,2019-07-12 07:14:00-04:00,ILMN,neutral
659768.0,"5 Stocks To Watch For July 12, 2019",2019-07-12 05:17:00-04:00,ILMN,neutral
659769.0,"Hookipa, EMCORE Making Big Moves In Thursday's After-Hours Session",2019-07-11 17:05:00-04:00,ILMN,neutral
659770.0,"UPDATE: Illumina Sees Sequencing Sales Up ~10% Year Over Year, Sequencing Service, Other Down Slightly, Array Sales Down ~14%, NovaSeq Shipments Flat To Up Slightly",2019-07-11 16:14:00-04:00,ILMN,neutral
659771.0,UPDATE: Illumina Cites 4 Items For Prelim. Q2 Guidance,2019-07-11 16:13:00-04:00,ILMN,neutral
659772.0,Illumina shares are trading lower after the company reported preliminary Q2 sales below analyst estimates.,2019-07-11 16:09:00-04:00,ILMN,neutral
659773.0,Illumina Sees FY19 Sales Growth ~6%,2019-07-11 16:06:00-04:00,ILMN,positive
659774.0,Illumina Sees Prelim. Q2 Sales $835M vs $888.18M Est.,2019-07-11 16:06:00-04:00,ILMN,neutral
659775.0,"The Daily Biotech Pulse: FDA Approves Karyopharm's Blood Cancer Treatment, Grifols' Immunodeficiency Drug; ESMO, ISTH Conferences In The Spotlight",2019-07-05 08:55:00-04:00,ILMN,negative
659776.0,Moneygram International Takes Legal Action To Protect Its Intellectual Property In Response To Claims Filed Against It By Illumina,2019-07-02 12:29:00-04:00,ILMN,positive
659777.0,"Top 10 Most Overbought Stocks Via Benzinga Pro's Radar Tool For Friday, June 28, 2019",2019-06-28 16:30:00-04:00,ILMN,positive
659778.0,"Top 10 Most Overbought Stocks Via Benzinga Pro's Radar Tool For Fri., June 28, 2019",2019-06-28 13:42:00-04:00,ILMN,positive
659779.0,"Illumina Files Patent Infringement Suits Related To BGI In Switzerland, Turkey And US",2019-06-28 09:05:00-04:00,ILMN,negative
659780.0,"Top 10 Most Overbought Stocks Via Benzinga Pro's Radar Tool For Thur., June 27, 2019",2019-06-27 12:43:00-04:00,ILMN,positive
659781.0,"Illumina Wins Infringement Suit Against Ariosa Diagnostics, Inc.",2019-06-17 16:05:00-04:00,ILMN,positive
659782.0,Many US-traded stocks are trading higher as recent economic signals have raised the potential for a Federal Reserve rate cut.,2019-06-07 12:31:00-04:00,ILMN,negative
659783.0,MGI Sues Illumina For Patent Infringement In United States,2019-05-29 12:35:00-04:00,ILMN,negative
659784.0,Illumina Reports Filing Of Patent Infringement Suit Against BGI In Denmark,2019-05-15 09:04:00-04:00,ILMN,negative
659785.0,"Shares of several healthcare companies are trading higher as the US market rebounds from recent weakness, driven by renewed cautious optimism surrounding US-China trade talks.",2019-05-14 13:32:00-04:00,ILMN,positive
659786.0,"Disney, Illumina And More: 'Fast Money Halftime Report' Picks For May 8",2019-05-08 15:22:00-04:00,ILMN,neutral
659787.0,"Shares of companies in the diagnostics and research space are trading higher in sympathy with Bruker, which reported better-than-expected Q1 EPS and sales results.",2019-05-03 13:21:00-04:00,ILMN,positive
659788.0,"The Daily Biotech Pulse: Mixed Results For Merck's Keytruda In Stomach Cancer; Roche's Spark-Buy Delayed, Teva Recalls Hypertension Drug",2019-04-26 08:02:00-04:00,ILMN,negative
659789.0,Illumina Sees FY19 Adj. EPS $6.63-$6.73 vs $6.53 Est.,2019-04-25 17:12:00-04:00,ILMN,neutral
659790.0,"Illumina Q1 Adj. EPS $1.6 Beats $1.37 Estimate, Sales $846M Beat $835.22M Estimate",2019-04-25 17:10:00-04:00,ILMN,neutral
659791.0,"The Daily Biotech Pulse: Adverum Gets New CFO, Flexion's Osteoarthritis Trial, Bristol-Myers Earnings",2019-04-25 07:58:00-04:00,ILMN,neutral
659792.0,"Earnings Scheduled For April 25, 2019",2019-04-25 04:26:00-04:00,ILMN,neutral
659793.0,"The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs",2019-04-21 14:06:00-04:00,ILMN,neutral
659794.0,Shares of several healthcare companies are trading lower after Trump renewed his efforts to repeal and replace the Affordable Care Act; the Department of Justice moved to accelerate the appeal process in hopes to invalidate the ACA as unconstitutional.BZ,2019-04-17 13:02:00-04:00,ILMN,positive
659795.0,Get In On Genomics With This New ETF,2019-04-10 08:01:00-04:00,ILMN,neutral
659796.0,Illumina Reports Filing Of Patent Infringement Suit Against BGI In Germany,2019-03-29 09:02:00-04:00,ILMN,negative
659797.0,"The Daily Biotech Pulse: NASH Disappointment For Gilead, Xeris To Offer Shares",2019-02-12 08:04:00-05:00,ILMN,negative
659798.0,"Jim Cramer Gives His Opinion On Cronos, Etsy And More",2019-02-12 07:49:00-05:00,ILMN,neutral
659799.0,"The Week Ahead In Biotech: Conferences, Clinical Trials, Earnings And IPOs",2019-02-03 10:09:00-05:00,ILMN,neutral
659800.0,62 Biggest Movers From Yesterday,2019-01-31 05:06:00-05:00,ILMN,neutral
659801.0,48 Stocks Moving In Wednesday's Mid-Day Session,2019-01-30 12:39:00-05:00,ILMN,neutral
659802.0,Morgan Stanley: Illumina's Q1 Guidance Puts 2019 Targets In Question,2019-01-30 10:58:00-05:00,ILMN,neutral
659803.0,Illumina shares are trading lower after Leerink Swan lowered its price target for the stock from $380 to $365 per share and pharmaceutical giant Amgen announced disappointing 2019 financial expectations.,2019-01-30 10:45:00-05:00,ILMN,negative
659804.0,7 Biggest Price Target Changes For Wednesday,2019-01-30 09:44:00-05:00,ILMN,neutral
659805.0,"The Daily Biotech Pulse: Roche Scraps Alzheimer's Disease Trials, Amgen Issues Weak Guidance",2019-01-30 08:12:00-05:00,ILMN,negative
659806.0,Illumina Sees FY19 Adj. EPS $6.50-$6.60 vs $6.46 Estimate,2019-01-29 16:05:00-05:00,ILMN,neutral
659807.0,"Illumina Q4 EPS $1.32 Misses $1.36 Estimate, Sales $867M Beat $862.42M Estimate",2019-01-29 16:05:00-05:00,ILMN,negative
659808.0,"The Daily Biotech Pulse: Big Pharma Earnings, Kiniksa Offering, FDA Decision Day For Aquestive",2019-01-29 07:25:00-05:00,ILMN,neutral
659809.0,Illumina's Q4 Earnings Outlook,2019-01-29 07:24:00-05:00,ILMN,neutral
659810.0,"Earnings Scheduled For January 29, 2019",2019-01-29 04:13:00-05:00,ILMN,neutral
659811.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings",2019-01-27 16:07:00-05:00,ILMN,neutral
659812.0,"Benzinga's Top Upgrades, Downgrades For January 25, 2019",2019-01-25 09:10:00-05:00,ILMN,positive
659813.0,Deutsche Bank Downgrades Illumina to Hold,2019-01-25 07:11:00-05:00,ILMN,neutral
659814.0,38 Stocks Moving In Tuesday's Mid-Day Session,2019-01-08 12:46:00-05:00,ILMN,neutral
659815.0,24 Stocks Moving In Tuesday's Pre-Market Session,2019-01-08 08:19:00-05:00,ILMN,neutral
659816.0,"The Daily Biotech Pulse: Amgen Slashes Cholesterol Drug Device Prices By 60%, Takeda Completes Shire Purchase",2019-01-08 08:15:00-05:00,ILMN,negative
659817.0,"Morgan Stanley Maintains Equal-Weight on Illumina, Lowers Price Target to $288",2019-01-07 08:47:00-05:00,ILMN,negative
659818.0,"UBS Upgrades Illumina to Buy, Raises Price Target to $370",2019-01-03 08:42:00-05:00,ILMN,neutral
659819.0,"Jim Cramer Weighs In On Exelon, Okta, Wrkco And More",2018-12-04 07:25:00-05:00,ILMN,neutral
659820.0,Illumina Shares Fall From Open As Traders Circulating Comments From Unknown Firm Suggesting Co. Could Experiencing Selling Pressure Given A Recent Warning By LabCorp Citing Slower Growth In Its Referred Direct-To-Consumer Genetic Testing,2018-11-30 09:33:00-05:00,ILMN,positive
659821.0,74 Biggest Movers From Friday,2018-11-05 04:36:00-05:00,ILMN,neutral
659822.0,Mid-Afternoon Market Update: Dow Falls 270 Points; Weight Watchers Shares Tumble After Q3 Results,2018-11-02 14:22:00-04:00,ILMN,positive
659823.0,64 Stocks Moving In Friday's Mid-Day Session,2018-11-02 12:44:00-04:00,ILMN,neutral
659824.0,Mid-Day Market Update: Dow Down 100 Points; Pacific Biosciences of California Shares Spike Higher,2018-11-02 12:18:00-04:00,ILMN,positive
659825.0,Mid-Morning Market Update: Markets Mostly Higher; Apple Issues Weak Sales Forecast,2018-11-02 10:15:00-04:00,ILMN,negative
659826.0,Illumina Buys Rival Pacific Biosciences In $1.2B Deal,2018-11-02 08:32:00-04:00,ILMN,neutral
659827.0,34 Stocks Moving In Friday's Pre-Market Session,2018-11-02 08:12:00-04:00,ILMN,neutral
659828.0,"The Daily Biotech Pulse: Illumina Snaps Up Pacific Bioscience, Thumbs Down For Alkermes Depressive Disorder Drug",2018-11-02 08:01:00-04:00,ILMN,negative
659829.0,Illumina To Purchase Pacific Biosciences For $8/Share In Cash,2018-11-01 16:02:00-04:00,ILMN,neutral
659830.0,Illumina Launches TruSight Oncology 500,2018-10-30 17:01:00-04:00,ILMN,neutral
659831.0,"Barclays Maintains Overweight on Illumina, Raises Price Target to $370",2018-10-24 10:56:00-04:00,ILMN,negative
659832.0,"The Daily Biotech Pulse: Illumina's Strong Q3, Celgene's Positive Cancer Drug Trial, Proteostasis Offering",2018-10-24 07:48:00-04:00,ILMN,positive
659833.0,"Illumina Raises FY18 Adj. EPS Guidance From $5.35-$5.45 As Of Jul. 30, 2018 To $5.70-$5.75 vs $5.45 Estimate",2018-10-23 16:06:00-04:00,ILMN,neutral
659834.0,"Illumina Q3 EPS $1.52 Beats $1.26 Estimate, Sales $853M Beat $828.48M Estimate",2018-10-23 16:05:00-04:00,ILMN,neutral
659835.0,"The Daily Biotech Pulse: Regulus Soars On Positive Pre-Clinical Data, Biogen Earnings, Proteostasis And Eiger to Offer Shares",2018-10-23 08:35:00-04:00,ILMN,positive
659836.0,Q3 Earnings Preview For Illumina,2018-10-23 07:58:00-04:00,ILMN,neutral
659837.0,"Earnings Scheduled For October 23, 2018",2018-10-23 04:22:00-04:00,ILMN,neutral
659838.0,Surverying The Q3 Earnings Heat Map,2018-10-16 13:30:00-04:00,ILMN,neutral
659839.0,"The Daily Biotech Pulse: FDA Nods For Adamis, Eli Lilly, Pfizer; Spero, Obseva Report Positive Trial Results",2018-09-28 08:10:00-04:00,ILMN,positive
659840.0,"Stocks That Made New 52-Week Highs So Far Today Include: TJX Companies, HCA Healthcare , Vertex Pharma, F5 Networks, Amgen, Tractor Supply, Visa, Illumina, Cooper Companies, CF Industries, Activision Blizzard, Salesforce, and Aon",2018-09-27 13:36:00-04:00,ILMN,neutral
659841.0,"Stocks Which Set New 52-Week High Yesterday, September 26th",2018-09-27 09:12:00-04:00,ILMN,neutral
659842.0,"Stocks That Made New 52-Week Highs So Far Today Include: Becton Dickinson, PerkinElmer, TJX Companies, Medtronic, Danaher, Mastercard, Visa, Illumina, Motorola Solutions, Salesforce, Ross Stores, Edward Lifesciences, and Boston Scientific",2018-09-26 12:58:00-04:00,ILMN,positive
659843.0,"Stocks Which Set New 52-Week High Yesterday, September 25th",2018-09-26 11:53:00-04:00,ILMN,neutral
659844.0,"Stocks That Made New 52-Week Highs So Far Today Include: Textron, Fiserv, Intuitive Surgical, Mosaic, Paychex, Juniper Networks, F5 Networks, Gartner, Cooper Companies, Edwards Lifesciences, Boston Scientific, Illumina, Yum Brands, and Align Technology",2018-09-25 13:02:00-04:00,ILMN,neutral
659845.0,"Stocks Which Set New 52-Week High Friday, September 21",2018-09-24 09:43:00-04:00,ILMN,neutral
659846.0,"Stocks Which Set New 52-Week High Friday, August 31",2018-09-04 10:29:00-04:00,ILMN,neutral
659847.0,"Stocks Which Set New 52-Week High Yesterday, August 30th",2018-08-31 10:11:00-04:00,ILMN,neutral
659848.0,"The Daily Biotech Pulse: FDA Blessings for Merck's HIV Drug Combo, Veracyte's Test Gets Medicare Coverage",2018-08-31 08:29:00-04:00,ILMN,positive
659849.0,"Stocks That Made New 52-Week Highs Today Include: FLIR Systems, Textron, Darden Restaurants, United Continental, Intuitive Surgical, TJX, NetApp, Illumina, First Energy, NVIDIA, Microsoft, Visa, and Paypal",2018-08-30 15:08:00-04:00,ILMN,positive
659850.0,"Stocks Which Set New 52-Week High Yesterday, August 28th",2018-08-29 11:13:00-04:00,ILMN,neutral
659851.0,"The Daily Biotech Pulse: Regulatory Roadblock For Akcea-Ionis, Affimed's Alliance, FDA Nod For Tetraphase's Antibiotic",2018-08-28 08:13:00-04:00,ILMN,neutral
659852.0,Illumina Receives Chinese National Drug Administration Approval Of Its MiSeq DX Sequencing System,2018-08-27 16:05:00-04:00,ILMN,negative
659853.0,"Stocks That Made New 52-Week Highs So Far Today Include: IHS Markit, Cooper Cos., IDEXX Labs, Motorola Solutions, Emerson, Sherwin-Williams, Kansas City Southern, Norfolk Southern, Archer-Daniels, Verisk, Illumina, CSX, AMD, Eli Lilly, & Union Pacific",2018-08-27 13:24:00-04:00,ILMN,positive
659854.0,"Stocks Which Set New 52-Week High Friday, August 24th",2018-08-27 09:24:00-04:00,ILMN,neutral
659855.0,10 Biggest Price Target Changes For Friday,2018-08-10 09:59:00-04:00,ILMN,neutral
659856.0,"Argus Maintains Buy on Illumina, Raises Price Target to $372",2018-08-10 09:03:00-04:00,ILMN,neutral
659857.0,"Stocks Which Set New 52-Week High Yesterday, August 7th",2018-08-08 11:01:00-04:00,ILMN,neutral
659858.0,"Market, Policy Trends Are Shifting In Illumina's Favor, Morgan Stanley Says In Upgrade",2018-08-07 11:43:00-04:00,ILMN,positive
659859.0,"Stocks Which Set New 52-Week High Yesterday, August 6th",2018-08-07 11:27:00-04:00,ILMN,neutral
659860.0,10 Biggest Price Target Changes For Tuesday,2018-08-07 10:05:00-04:00,ILMN,neutral
659861.0,"Benzinga's Top Upgrades, Downgrades For August 7, 2018",2018-08-07 09:03:00-04:00,ILMN,positive
659862.0,"Morgan Stanley Upgrades Illumina to Equal-Weight, Raises Price Target to $320",2018-08-07 06:43:00-04:00,ILMN,neutral
659863.0,Morgan Stanley Upgrades Illumina to Equal-Weigh from Underweight; Raises Price Target to $320 from $210,2018-08-07 04:12:00-04:00,ILMN,neutral
659864.0,"Stocks That Made New 52-Week Highs So Far Today Include: CSX, Jacobs Engineering, Medtronic, United Continental, Cintas, Advance Auto Parts, O'Reilly Automotive, Robert Half, Norfolk Southern, Verisk Analytics, NextEra Energy, Pfizer, Apple, & Illumina",2018-08-06 15:50:00-04:00,ILMN,positive
659865.0,"Stocks Which Set New 52-Week Highs Friday, August 3rd",2018-08-06 13:02:00-04:00,ILMN,neutral
659866.0,"Stocks Which Set New 52-Week High Yesterday, August 2nd",2018-08-03 11:16:00-04:00,ILMN,neutral
659867.0,"The Daily Biotech Pulse: Zafgen Executive Departs; Adamas, Acceleron Accelerate On Earnings",2018-08-03 07:52:00-04:00,ILMN,neutral
659868.0,"Stocks Which Set New 52-Week High Yesterday, August 1st",2018-08-02 10:56:00-04:00,ILMN,neutral
659869.0,"Stocks That Have Made New 52 Week Highs Thus Far Today Include: Robert Half, Eli Lilly, Pfizer, Phillips 66, Humana, HCA Healthcare, Genworth, Republic Services, Illumina, Aflac, Medtronic, Waste Management, and Apple",2018-08-01 13:32:00-04:00,ILMN,negative
659870.0,"Stocks Which Set New 52-Week High Yesterday, July 31",2018-08-01 12:04:00-04:00,ILMN,neutral
659871.0,"Benzinga's Biotech Pulse: Pfizer's Xeljanz Gets EU Nod, NewLink Losses Narrow, Neuralstem Commences Stroke Drug Trial",2018-08-01 09:01:00-04:00,ILMN,negative
659872.0,65 Biggest Movers From Yesterday,2018-08-01 04:36:00-04:00,ILMN,neutral
659873.0,52 Stocks Moving In Tuesday's Mid-Day Session,2018-07-31 12:38:00-04:00,ILMN,neutral
659874.0,Illumina Shares Up 11% After Co. Announces Strong 2Q Financial Results Showing Cash Flow Up 66%; Slew Of Analysts Raised Co.'s Price Target Tuesday Morning,2018-07-31 11:53:00-04:00,ILMN,positive
659875.0,"Bank of America Maintains Buy on Illumina, Raises Price Target to $370",2018-07-31 10:22:00-04:00,ILMN,neutral
659876.0,10 Biggest Price Target Changes For Tuesday,2018-07-31 09:26:00-04:00,ILMN,neutral
659877.0,"Barclays Maintains Overweight on Illumina, Raises Price Target to $350",2018-07-31 08:45:00-04:00,ILMN,negative
659878.0,"Deutsche Bank Maintains Buy on Illumina, Raises Price Target to $330",2018-07-31 08:12:00-04:00,ILMN,neutral
659879.0,"Canaccord Genuity Maintains Buy on Illumina, Raises Price Target to $340",2018-07-31 08:07:00-04:00,ILMN,neutral
659880.0,30 Stocks Moving In Tuesday's Pre-Market Session,2018-07-31 08:00:00-04:00,ILMN,neutral
659881.0,"Citigroup Maintains Buy on Illumina, Raises Price Target to $345",2018-07-31 07:41:00-04:00,ILMN,neutral
659882.0,"12 Stocks To Watch For July 31, 2018",2018-07-31 04:46:00-04:00,ILMN,neutral
659883.0,8 Stocks Moving In Monday's After-Hours Session,2018-07-30 17:03:00-04:00,ILMN,neutral
659884.0,"Illumina Sees FY18 Adj. EPS $5.35-$5.45 vs $4.87 Est., Sales Growth 20%",2018-07-30 16:06:00-04:00,ILMN,positive
659885.0,"Illumina Q2 Adj. EPS $1.43 Beats $1.11 Estimate, Sales $830M Beat $786.37M Estimate",2018-07-30 16:05:00-04:00,ILMN,neutral
659886.0,Illumina Q2 Earnings Preview,2018-07-30 07:22:00-04:00,ILMN,neutral
659887.0,"Earnings Scheduled For July 30, 2018",2018-07-30 04:58:00-04:00,ILMN,neutral
659888.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings And IPOs",2018-07-28 14:04:00-04:00,ILMN,neutral
659889.0,"Stocks Which Set New 52-Week High Yesterday, July 26th:",2018-07-27 10:42:00-04:00,ILMN,neutral
659890.0,"Stocks Which Set New 52-Week High Yesterday, July 25th",2018-07-26 11:00:00-04:00,ILMN,neutral
659891.0,"Benzinga's Daily Biotech Pulse: Biogen, AC Immune Slip Despite Positive Trials, Sarepta Slapped With Clinical Hold",2018-07-26 08:40:00-04:00,ILMN,negative
659892.0,"PiperJaffray Maintains Overweight on Illumina, Raises Price Target to $329",2018-07-17 08:24:00-04:00,ILMN,negative
659893.0,8 Biggest Price Target Changes For Friday,2018-07-13 09:46:00-04:00,ILMN,neutral
659894.0,"Morgan Stanley Maintains Underweight on Illumina, Raises Price Target to $210",2018-07-13 07:50:00-04:00,ILMN,neutral
659895.0,"Benzinga's Daily Biotech Pulse: AbbVie Files sNDA For Leukemia Drug, AcelRx Offering, Aurinia Starts Mid-Stage Trial",2018-07-12 08:37:00-04:00,ILMN,neutral
659896.0,"Stocks That Made New 52 Week Highs Today Include: Intuitive Surgical, Salesforce, Humana, Motorola, Illumina, Archer-Daniels, Visa, and Church & Dwight; American Airlines Made New 52 Week Low Today",2018-07-11 10:23:00-04:00,ILMN,negative
659897.0,7 Biggest Price Target Changes For Tuesday,2018-07-10 09:39:00-04:00,ILMN,neutral
659898.0,"Cowen & Co. Maintains Outperform on Illumina, Raises Price Target to $315",2018-07-10 07:50:00-04:00,ILMN,neutral
659899.0,7 Biggest Price Target Changes For Monday,2018-06-25 09:44:00-04:00,ILMN,neutral
659900.0,"Citigroup Maintains Buy on Illumina, Raises Price Target to $330",2018-06-25 08:00:00-04:00,ILMN,neutral
659901.0,"William Blair Growth Stock Conference Continues Today, Presenters Include: Zendesk, CURO, NetApp, Guidewire Software, Six Flags, 8 x 8, Arista Networks, llumina, Mastercard, and Visa",2018-06-13 07:30:00-04:00,ILMN,positive
659902.0,"Stocks That Made New 52-Week Highs Today Include: Adobe, Intuitive Surgical, Global Payments, Republic Services, Baxter International, Costco, Kohl's, Expeditors International, Centene, TJX Companies, Tiffany, Illumina, Salesforce, WW Grainger, and ONEOK",2018-06-12 14:52:00-04:00,ILMN,neutral
659903.0,"Morgan Stanley Maintains Underweight on Illumina, Raises Price Target to $195",2018-05-31 09:39:00-04:00,ILMN,neutral
659904.0,7 Biggest Price Target Changes For Tuesday,2018-05-29 10:37:00-04:00,ILMN,neutral
659905.0,"Canaccord Genuity Maintains Buy on Illumina, Raises Price Target to $290",2018-05-29 08:41:00-04:00,ILMN,neutral
659906.0,24 Stocks Moving In Friday's Pre-Market Session,2018-05-18 08:04:00-04:00,ILMN,neutral
659907.0,"Illumina Reports Will Purchase Edico Genome, No Terms Disclosed",2018-05-15 09:00:00-04:00,ILMN,negative
659908.0,"Benzinga's Daily Biotech Pulse: Aytu Rallies On Earnings, Evolus Awaits FDA Verdict, BofA Conference Underway",2018-05-15 08:44:00-04:00,ILMN,positive
659909.0,"Benzinga's Daily Biotech Pulse: ARMO Skyrockets On Eli Lilly Deal, Akcea Meets FDA Panel, vTv Alzheimer's Trial Results",2018-05-10 09:44:00-04:00,ILMN,neutral
659910.0,31 Biggest Movers From Yesterday,2018-05-08 05:12:00-04:00,ILMN,neutral
659911.0,"Stocks That Made New 52-Week Highs Today Include: IHS Markit, E*TRADE, Boston Scientific, Red Hat, Sysco, Illumina, Mastercard, Anadarko Petroleum, and Citrix Systems",2018-05-07 15:51:00-04:00,ILMN,neutral
659912.0,26 Stocks Moving In Monday's Mid-Day Session,2018-05-07 13:15:00-04:00,ILMN,neutral
659913.0,"Benzinga's Top Upgrades, Downgrades For May 7, 2018",2018-05-07 09:20:00-04:00,ILMN,positive
659914.0,"The Market In 5 Minutes: Oil, NAFTA, Buffett, Volkswagen And More",2018-05-07 09:00:00-04:00,ILMN,neutral
659915.0,Barclays Upgrades Illumina to Overweight,2018-05-07 06:20:00-04:00,ILMN,negative
659916.0,"Barclays Maintains Equal-Weight on Illumina, Raises Price Target to $235.00",2018-04-25 11:56:00-04:00,ILMN,neutral
659917.0,7 Biggest Price Target Changes For Wednesday,2018-04-25 09:55:00-04:00,ILMN,neutral
659918.0,"Morgan Stanley Maintains Underweight on Illumina, Raises Price Target to $180.00",2018-04-25 09:09:00-04:00,ILMN,neutral
659919.0,"Baird Maintains Outperform on Illumina, Raises Price Target to $271.00",2018-04-25 08:30:00-04:00,ILMN,neutral
659920.0,"Illumina Sees FY18 Adj. EPS $4.75-$4.85 vs $4.59 Est., Sales Growth Of 15-16%",2018-04-24 16:06:00-04:00,ILMN,positive
659921.0,"Illumina Q1 EPS $1.45 Beats $1.02 Est., Sales $782M Beats $743M Est.",2018-04-24 16:05:00-04:00,ILMN,neutral
659922.0,"Earnings Scheduled For April 24, 2018",2018-04-24 04:14:00-04:00,ILMN,neutral
659923.0,"Bristol-Myers Squibb, Illumina Report Strategic Collaboration To Develop, Commercialize Companion Diagnostics For Bristol's Oncology Immunotherapies",2018-04-13 16:15:00-04:00,ILMN,neutral
659924.0,"Morgan Stanley Maintains Underweight on Illumina, Raises Price Target to $170.00",2018-04-11 07:40:00-04:00,ILMN,neutral
659925.0,Illumina and Loxo Oncology to Partner on Sequencing-Based Pan-Cancer Companion Diagnostics,2018-04-10 06:46:00-04:00,ILMN,neutral
659926.0,Illumina Names Dr. Phil Febbo Chief Medical Officer,2018-03-12 16:16:00-04:00,ILMN,neutral
659927.0,Anhui Anke Biotechnology Unit Obtains Exclusive Distribution Rights in China for Verogen's Products,2018-03-05 19:11:00-05:00,ILMN,positive
659928.0,7 Biggest Price Target Changes For Tuesday,2018-02-06 11:46:00-05:00,ILMN,neutral
659929.0,"Citigroup Maintains Buy on Illumina, Raises Price Target to $275.00",2018-02-06 08:37:00-05:00,ILMN,neutral
659930.0,"Barclays Maintains Equal-Weight on Illumina, Raises Price Target to $215.00",2018-01-31 11:46:00-05:00,ILMN,neutral
659931.0,5 Biggest Price Target Changes For Wednesday,2018-01-31 10:12:00-05:00,ILMN,neutral
659932.0,"Benzinga's Top Upgrades, Downgrades For January 31, 2018",2018-01-31 09:21:00-05:00,ILMN,positive
659933.0,"Morgan Stanley Maintains Underweight on Illumina, Raises Price Target to $157.00",2018-01-31 09:02:00-05:00,ILMN,neutral
659934.0,"Leerink Swann Maintains Outperform on Illumina, Raises Price Target to $276.00",2018-01-31 08:41:00-05:00,ILMN,neutral
659935.0,First Analysis Upgrades Illumina to Overweight,2018-01-31 07:52:00-05:00,ILMN,negative
659936.0,Illumina Sees FY18 Adj. EPS $4.50-$4.60 vs $4.58 Est.,2018-01-30 16:07:00-05:00,ILMN,neutral
659937.0,"Illumina Reports Q4 Adj. EPS $1.44 vs $1.22 Est., Sales $778M vs $750.2M Est.",2018-01-30 16:05:00-05:00,ILMN,neutral
659938.0,Illumina Q4 Earnings Preview,2018-01-30 08:41:00-05:00,ILMN,neutral
659939.0,"Earnings Scheduled For January 30, 2018",2018-01-30 04:02:00-05:00,ILMN,neutral
659940.0,"The Week Ahead: Big Tech Earnings, Fed Rate Decision Likely To Dominate Headlines",2018-01-29 14:45:00-05:00,ILMN,negative
659941.0,Illumina Reports Winning Of $26.7M In Patent Suit Against Ariosa Diagnostics,2018-01-26 16:07:00-05:00,ILMN,positive
659942.0,Illumina Shares Unaffected Amid Report US Jury Awarded Co. $26.7M In Patent Case Against Roche,2018-01-25 15:45:00-05:00,ILMN,positive
659943.0,"Illumina To Report Q4 Earnings Tues., Jan. 30 After Market Close",2018-01-16 10:04:00-05:00,ILMN,neutral
659944.0,40 Biggest Movers From Yesterday,2018-01-10 04:34:00-05:00,ILMN,neutral
659945.0,40 Stocks Moving In Tuesday's Mid-Day Session,2018-01-09 12:28:00-05:00,ILMN,neutral
659946.0,25 Stocks Moving In Tuesday's Pre-Market Session,2018-01-09 08:29:00-05:00,ILMN,neutral
659947.0,Watch Shares of Illumina After the Company Announces an Agreement with Thermo Fisher to Sell Ion AmpliSeq Technology and Announced the Launch of its Sequencing Technology iSeq 100,2018-01-09 07:57:00-05:00,ILMN,positive
659948.0,"JP Morgan Healthcare Conference Begins Today, Presenters Include: Gilead, Illumina, Seattle Genetics, Biogen, Incyte, Baxter, Regeneron, Walgreens, Alnylam, Edwards Lifesciences, Molina, Alexion, Celgene, Pfizer, Neurocrine Biosciences, and Jazz Pharma",2018-01-08 09:00:00-05:00,ILMN,positive
659949.0,Guangzhou Kingmed Diagnostics Says Unit Signs Agreement With Illumina To Buy Genes-Related Testing Equipment Such As Miniseq -Reuters,2018-01-08 07:18:00-05:00,ILMN,positive
659950.0,"Benzinga's Top Upgrades, Downgrades For January 5, 2018",2018-01-05 09:11:00-05:00,ILMN,positive
659951.0,William Blair Downgrades Illumina to Market Perform,2018-01-05 08:26:00-05:00,ILMN,neutral
659952.0,BTIG Research Initiates Coverage On Illumina with Neutral Rating,2018-01-05 06:38:00-05:00,ILMN,neutral
659953.0,"Benzinga's Top Upgrades, Downgrades For January 4, 2018",2018-01-04 09:51:00-05:00,ILMN,positive
659954.0,"Evercore ISI Group Initiates Coverage On Illumina with Outperform Rating, Announces $250.00 Price Target",2018-01-04 08:43:00-05:00,ILMN,neutral
659955.0,"Illumina, KingMed Diagnostics Reports Partnership To Develop Next Gen Sequencing Technology For Chinese FDA Approval",2018-01-04 08:36:00-05:00,ILMN,positive
659956.0,"Benzinga's Top Upgrades, Downgrades For January 2, 2018",2018-01-02 09:29:00-05:00,ILMN,positive
659957.0,Wells Fargo Upgrades Illumina to Outperform,2018-01-02 07:27:00-05:00,ILMN,positive
659958.0,UPDATE: HTG Says 'third development plan relates to a pharmaceutical company project and the planned development and intended regulatory approval of an IVD test kit designed for RNA detection in the field of diagnostic oncology testing in humans',2017-12-27 16:18:00-05:00,ILMN,positive
659959.0,HTG Molecular Diagnostics 8-K Shows Co. Entered Third Development Plan With Illumina,2017-12-27 16:17:00-05:00,ILMN,neutral
659960.0,HTG Molecular's Deal With Merck KGaA 'Provides Further Validation' For EdgeSeq Technology,2017-12-27 13:18:00-05:00,ILMN,neutral
659961.0,"Disney Names Oracle CEO Safra Catz, Illumina Pres, CEO Francis deSouza To Board",2017-12-07 16:47:00-05:00,ILMN,neutral
659962.0,Illumina Opens First Commercial and Customer Training Center in France,2017-11-29 04:13:00-05:00,ILMN,neutral
659963.0,"Illumina Reports Winning Of Infringement Suit Against Premaitha Health, Ariosa Diagnostics",2017-11-21 16:14:00-05:00,ILMN,positive
659964.0,Illumina Reported Its Fastest Top-line Growth Since 2015,2017-10-25 09:47:00-04:00,ILMN,positive
659965.0,"Benzinga's Top Upgrades, Downgrades For October 25, 2017",2017-10-25 09:12:00-04:00,ILMN,positive
659966.0,Baird Upgrades Illumina to Outperform,2017-10-25 07:40:00-04:00,ILMN,neutral
659967.0,13 Stocks Moving In Tuesday's After-Hours Session,2017-10-24 17:26:00-04:00,ILMN,neutral
659968.0,Illumina Sees FY17 Adj. EPS $3.73-$3.78 vs $3.65 Est.,2017-10-24 16:06:00-04:00,ILMN,neutral
659969.0,"Illumina Reports Q3 Adj. EPS $1.11 vs $0.99 Est., Sales $714M vs $693.3M Est.",2017-10-24 16:06:00-04:00,ILMN,neutral
659970.0,"Earnings Scheduled For October 24, 2017",2017-10-24 04:09:00-04:00,ILMN,neutral
659971.0,Deutsche Bank Brightens Its View On Illumina,2017-10-23 13:44:00-04:00,ILMN,positive
659972.0,"Benzinga's Top Upgrades, Downgrades For October 23, 2017",2017-10-23 09:19:00-04:00,ILMN,positive
659973.0,Deutsche Bank Upgrades Illumina to Buy,2017-10-23 08:31:00-04:00,ILMN,neutral
659974.0,Janney Capital Upgrades Illumina to Neutral,2017-10-23 08:30:00-04:00,ILMN,neutral
659975.0,Illumina Spikes to High of $205.06 on Volume,2017-10-11 12:43:00-04:00,ILMN,neutral
659976.0,Illumina Reports Filing Of New Patent Infringement Suit Against Premaitha Health,2017-09-07 09:01:00-04:00,ILMN,negative
659977.0,"Illumina Now A Buy Following Q2 Beat, Improved Sales Outlook",2017-08-07 14:49:00-04:00,ILMN,positive
659978.0,7 Biggest Price Target Changes For Monday,2017-08-07 10:08:00-04:00,ILMN,neutral
659979.0,"Benzinga's Top Upgrades, Downgrades For August 7, 2017",2017-08-07 09:49:00-04:00,ILMN,positive
659980.0,The Market In 5 Minutes,2017-08-07 08:45:00-04:00,ILMN,neutral
659981.0,"Canaccord Genuity Upgrades Illumina to Buy, Raises Price Target to $215.00",2017-08-07 06:21:00-04:00,ILMN,neutral
659982.0,Canaccord Genuity Upgrades Illumina to Buy from Hold; Raises PT to $215 from $170,2017-08-07 04:15:00-04:00,ILMN,neutral
659983.0,"Illumina Beats In Q2, But Investment Thesis Remains Unclear",2017-08-03 11:18:00-04:00,ILMN,negative
659984.0,18 Biggest Mid-Day Gainers For Wednesday,2017-08-02 12:21:00-04:00,ILMN,neutral
659985.0,"Benzinga's Top Upgrades, Downgrades For August 2, 2017",2017-08-02 09:24:00-04:00,ILMN,positive
659986.0,25 Stocks Moving In Wednesday's Pre-Market Session,2017-08-02 08:14:00-04:00,ILMN,neutral
659987.0,"Illumina Reports Q2 Adj. EPS $0.82 vs $0.69 Est., Sales $662M vs $642.4M Est.",2017-08-01 16:08:00-04:00,ILMN,neutral
659988.0,"Earnings Scheduled For August 1, 2017",2017-08-01 04:34:00-04:00,ILMN,neutral
659989.0,Genomics England Adopts Illumina's BaseSpace Variant Interpreter for Cancer,2017-06-26 04:02:00-04:00,ILMN,negative
659990.0,The 9 Best S&P 500 Stocks Of The Past 15 Years,2017-06-12 12:10:00-04:00,ILMN,positive
659991.0,Monday's Market In 5 Minutes,2017-05-30 08:31:00-04:00,ILMN,neutral
659992.0,"Bank Of America Health Care Conference Concludes Today; Presenters Include Boston Scientific, Humana, Universal Health, Chemed, Community Health, Eagle Pharma, Alnylam, Gilead, & Illumina",2017-05-18 08:53:00-04:00,ILMN,positive
659993.0,"Illumina Sees Q2 EPS $0.65-$0.70 Est $0.87 Est., FY17 EPS $3.60-$3.70 vs $4.32 Est.",2017-04-25 16:07:00-04:00,ILMN,neutral
659994.0,"Illumina Reports Q1 EPS $0.64 vs $0.64 Est., Sales $598M vs $590M Est.",2017-04-25 16:05:00-04:00,ILMN,neutral
659995.0,There's Something Wrong With Illumina's Gene Sequencing Machine,2017-04-24 12:30:00-04:00,ILMN,negative
659996.0,"Traders Attributing Weakness In Illumina To Negative Article From Wired, Says Gene Sequencing Technology Could Have Contaminated Results Of Recent High-Sensitivity Data Produced On Machines",2017-04-21 09:38:00-04:00,ILMN,negative
659997.0,What Would A $5.8 Billion NIH Cut Look Like? Devastation,2017-04-20 13:38:00-04:00,ILMN,negative
659998.0,"Kailos Genetics Reports Co-marketing Agreement with Illumina, Inc. for Pharmacogenetics Solution for Research",2017-03-21 09:01:00-04:00,ILMN,positive
659999.0,"Benzinga's Top Upgrades, Downgrades For March 20, 2017",2017-03-20 09:21:00-04:00,ILMN,positive
660000.0,Leerink Swann Upgrades Illumina To Outperform,2017-03-20 06:46:00-04:00,ILMN,neutral
660001.0,"Munich Leukemia Laboratory Selects IBM Watson, Illumina for Leukemia Research Collaboration",2017-03-08 04:19:00-05:00,ILMN,neutral
660002.0,"Cowen Annual Healthcare Conference Continues Today; Presenters Include Regulus, Eli Lilly, Oculus, DexCom, Illumina, Allergan, Kite Pharma, Pfizer, and bluebird bio",2017-03-07 08:59:00-05:00,ILMN,neutral
660003.0,OPKO Subsidiary GenPath Women's Health Reports Availability of ClariTest,2017-03-07 08:02:00-05:00,ILMN,neutral
660004.0,Illumina Shares Up ~0.4% Over Last Few Mins Following Spike to Session High of $171.21 on Heavy Volume,2017-03-02 15:22:00-05:00,ILMN,positive
660005.0,15 Biggest Mid-Day Gainers For Monday,2017-02-27 12:48:00-05:00,ILMN,neutral
660006.0,"Benzinga's Top Upgrades, Downgrades For February 27, 2017",2017-02-27 09:38:00-05:00,ILMN,positive
660007.0,Evercore ISI Group Upgrades Illumina To Buy,2017-02-27 06:39:00-05:00,ILMN,neutral
660008.0,Illumina Sees FY17 Adj. EPS $3.60-$3.70 vs $3.65 Est.,2017-01-31 16:30:00-05:00,ILMN,neutral
660009.0,Illumina Sees Q1 Rev. $580-$595M vs. Est. $618M,2017-01-31 16:30:00-05:00,ILMN,neutral
660010.0,"Illumina Reports Q4 Adj EPS $0.85 vs $0.82 Est, Revenue $619M vs $616.41M Est",2017-01-31 16:29:00-05:00,ILMN,neutral
660011.0,"Earnings Scheduled For January 31, 2017",2017-01-31 05:08:00-05:00,ILMN,neutral
660012.0,Q4 2016 Real-Time Call Brief,2017-01-30 19:00:00-05:00,ILMN,neutral
660013.0,"Even After Price Jump, Vetr Upgrades Illumina",2017-01-25 17:14:00-05:00,ILMN,neutral
660014.0,CareDx To Acquire SBT Resolver HLA Typing Products From Illumina,2017-01-24 16:57:00-05:00,ILMN,positive
660015.0,Deutsche Bank Optimistic On Fundamentals In Life Science Tools/Diagnostics Sector,2017-01-18 12:29:00-05:00,ILMN,positive
660016.0,"Benzinga's Top Upgrades, Downgrades For January 18, 2017",2017-01-18 09:42:00-05:00,ILMN,positive
660017.0,"Deutsche Bank Initiates Coverage On Illumina at Hold, Announces $160 Price Target",2017-01-18 08:36:00-05:00,ILMN,neutral
660018.0,15 Biggest Mid-Day Gainers For Tuesday,2017-01-10 12:27:00-05:00,ILMN,neutral
660019.0,Mid-Day Market Update: Dow Gains Over 50 Points; hhgregg Shares Plunge,2017-01-10 12:05:00-05:00,ILMN,positive
660020.0,"Baird Weighs In On Illumina's Guidance, NovaSeq Platform",2017-01-10 10:48:00-05:00,ILMN,neutral
660021.0,Illumina Shines At JPMorgan Conference With Bullish Prelim Guidance,2017-01-10 10:19:00-05:00,ILMN,neutral
660022.0,Mid-Morning Market Update: Markets Edge Lower; Barracuda Beats Q3 Expectations,2017-01-10 10:18:00-05:00,ILMN,negative
660023.0,7 Biggest Price Target Changes For Tuesday,2017-01-10 09:35:00-05:00,ILMN,neutral
660024.0,"Bank of America Upgrades Illumina to Buy, Raises Target to $175.00",2017-01-10 08:43:00-05:00,ILMN,neutral
660025.0,20 Stocks Moving In Tuesday's Pre-Market Session,2017-01-10 08:24:00-05:00,ILMN,neutral
660026.0,"Illumina Shares up 13% Premarket, In Yesterday's After-Hours Session, Illumina CEO Said He Saw Q4 Rev. Coming In At ~$619M For The Quarter at the JPMorgan Healthcare Conf.",2017-01-10 07:56:00-05:00,ILMN,positive
660027.0,"Illumina +18.46% Premarket @ $160 Following Upgrade at BofA Merrill; PT Raises at Leerink, Barclays",2017-01-10 07:11:00-05:00,ILMN,neutral
660028.0,IBM Watson and Illumina Partner to Standardize Genomic Data Interpretation,2017-01-09 09:11:00-05:00,ILMN,neutral
660029.0,Philips and Illumina Partner to Offer Integrated Genomics Solutions for Oncology,2017-01-09 08:53:00-05:00,ILMN,positive
660030.0,"Watch For Volatility In Illumina, As Intereconomia Reports Roche Interest In Acquiring Illumina",2017-01-05 15:23:00-05:00,ILMN,positive
660031.0,CNBC's List Of 20 Beaten-Up Stocks,2016-12-15 12:36:00-05:00,ILMN,neutral
660032.0,What Passage Of The 21st Century Cures Act Means For Biotech Stocks,2016-12-08 11:41:00-05:00,ILMN,neutral
660033.0,Biotech Stocks Convalescing After Wednesday's Trump-Inspired Biotech Selloff,2016-12-08 09:53:00-05:00,ILMN,neutral
660034.0,18 Biggest Mid-Day Losers For Wednesday,2016-12-07 13:03:00-05:00,ILMN,negative
660035.0,"Illumina Shares Down 4.24% Midday On Heavy Volume; Hearing Morgan Stanley Cut Price Target From $115 To $110, Reiterates Underweight Rating, Believes Top-Line Headwinds To Remain Going Into 2017",2016-12-07 12:47:00-05:00,ILMN,neutral
660036.0,Stocks Hitting 52-Week Lows,2016-12-07 10:27:00-05:00,ILMN,negative
660037.0,"Citi Global Healthcare Conf. Takes Place Today; Presenters Include Pfizer, Aerie Pharmaceuticals, Bristol-Myers, Alexion, Illumina, & Envision Healthcare",2016-12-07 08:38:00-05:00,ILMN,neutral
660038.0,10 Stocks With Lowest Close In Three Weeks,2016-12-07 07:07:00-05:00,ILMN,negative
660039.0,Illumina Announces Sam Samad CFO,2016-12-07 06:32:00-05:00,ILMN,neutral
660040.0,"The Market In 5 Minutes: Dow, S&P 500 Trading At All-Time Highs",2016-11-22 09:08:00-05:00,ILMN,neutral
660041.0,Wall Street's M&A Chatter From November 21,2016-11-22 06:47:00-05:00,ILMN,neutral
660042.0,Hearing Unconfirmed Market Chatter Roche May Bid $200/Share for Illumina,2016-11-21 09:36:00-05:00,ILMN,negative
660043.0,"Leerink Swann Assumes Illumina, Inc. - Common Stock at Market Perform",2016-11-10 09:35:00-05:00,ILMN,neutral
660044.0,"First Analysis Downgrades Illumina, Inc. - Common Stock to Underweight",2016-11-02 07:33:00-04:00,ILMN,neutral
660045.0,Illumina Sees FY16 EPS $3.27-$3.32 vs. Est. $3.38,2016-11-01 16:07:00-04:00,ILMN,neutral
660046.0,"Illumina Reports Q3 EPS $0.97 vs. Est. $0.87, Rev. $607.13M vs. Est. $614.3M",2016-11-01 16:07:00-04:00,ILMN,neutral
660047.0,"Earnings Scheduled For November 1, 2016",2016-11-01 04:52:00-04:00,ILMN,neutral
660048.0,Illumina and LabCorp Report German Court Issues Preliminary Injunction Against amedes Fetalis Test for Infringement of Non-Invasive Prenatal Screening Patent,2016-10-24 16:25:00-04:00,ILMN,negative
660049.0,Goldman Says These 25 Healthcare Stocks Are Immune To The Election,2016-10-24 10:55:00-04:00,ILMN,positive
660050.0,"Benzinga's M&A Chatter for Monday, October 17, 2016",2016-10-17 22:39:00-04:00,ILMN,neutral
660051.0,Ilumina Spikes to High of $139.48 on Volume; Traders Attributing to Betaville Report on Potential Roche Interest,2016-10-17 09:48:00-04:00,ILMN,positive
660052.0,"Argus Cuts Illumina's Price Target, But Still Believes In The Long-Term Picture",2016-10-13 13:12:00-04:00,ILMN,negative
660053.0,Earnings Season On Deck: How Has Q3 Guidance Looked So Far?,2016-10-12 16:06:00-04:00,ILMN,neutral
660054.0,"Wall Street Analysts React To Illumina's Concerning Outlook, Ensuing 25% Drop In Shares",2016-10-11 16:57:00-04:00,ILMN,neutral
660055.0,Mid-Afternoon Market Update: Dow Drops 250 Points; Biostar Pharmaceuticals Shares Spike Higher,2016-10-11 14:42:00-04:00,ILMN,positive
660056.0,Technical Alert: Ilumina Attempts To Recover,2016-10-11 14:33:00-04:00,ILMN,positive
660057.0,12 Biggest Mid-Day Losers For Tuesday,2016-10-11 12:30:00-04:00,ILMN,negative
660058.0,Mid-Day Market Update: Rent-A-Center Drops On Disappointing Q3 Outlook; Nymox Shares Surge,2016-10-11 12:27:00-04:00,ILMN,negative
660059.0,"Illumina: Same Issues, Different Quarter",2016-10-11 12:12:00-04:00,ILMN,neutral
660060.0,Mid-Morning Market Update: Markets Open Lower; Alcoa Misses Q3 Views,2016-10-11 10:02:00-04:00,ILMN,negative
660061.0,"For Illumina, A New Quarter Means A New Narrative ... Again",2016-10-11 09:51:00-04:00,ILMN,neutral
660062.0,Illumina's Poor Streak Is A Sign Of Market Saturation,2016-10-11 09:16:00-04:00,ILMN,negative
660063.0,Benzinga's Top Downgrades,2016-10-11 09:10:00-04:00,ILMN,positive
660064.0,"The Market In 5 Minutes: Oil Freeze, Alcoa Earnings, And Galaxy Note 7's Farewell",2016-10-11 09:00:00-04:00,ILMN,positive
660065.0,"Cantor Cuts Illumina's Price Target To $155, Positive On Pacific Biosciences Of California",2016-10-11 08:57:00-04:00,ILMN,positive
660066.0,"Janney Capital Downgrades Illumina, Inc. - Common Stock to Sell",2016-10-11 08:50:00-04:00,ILMN,neutral
660067.0,"CItigroup Downgrades Illumina, Inc. - Common Stock to Neutral",2016-10-11 08:49:00-04:00,ILMN,neutral
660068.0,14 Stocks Moving In Tuesday's Pre-Market Session,2016-10-11 08:33:00-04:00,ILMN,neutral
660069.0,Citi Loses Some Confidence In Illumina Following Disappointing Guidance,2016-10-11 07:30:00-04:00,ILMN,negative
660070.0,5 Stocks You Should Be Watching Today,2016-10-11 04:46:00-04:00,ILMN,neutral
660071.0,"3 Stocks Moving After-Hours: Dividends, Guidance Cuts & Analyst Coverage",2016-10-10 17:31:00-04:00,ILMN,negative
660072.0,"After-Hours Decliners Oct. 10, 2016: ILMN Down 24%, LC 2.3%, HRTG 1.7%",2016-10-10 17:20:00-04:00,ILMN,neutral
660073.0,"Illumina Shares Resume Trade, Now Down 24%",2016-10-10 16:35:00-04:00,ILMN,positive
660074.0,Illumina Shares to Resume Trade at 4:35 p.m. EDT,2016-10-10 16:10:00-04:00,ILMN,positive
660075.0,Illumina Sees Q4 Sales Flat to Slightly Up on QoQ Basis,2016-10-10 16:06:00-04:00,ILMN,neutral
660076.0,UPDATE: Illumina Cuts  Q3 Sales Outlook from $625M-$630M to ~$607M,2016-10-10 16:05:00-04:00,ILMN,negative
660077.0,Illumina Cuts Outlook,2016-10-10 16:05:00-04:00,ILMN,negative
660078.0,Illumina Shares Halted News Pending,2016-10-10 16:01:00-04:00,ILMN,positive
660079.0,First Two Weeks Of October EPS Estimates All In One Place,2016-10-03 06:43:00-04:00,ILMN,neutral
660080.0,CL King Downgrades Illumina to Neutral,2016-08-22 08:18:00-04:00,ILMN,neutral
660081.0,The Market In 5 Minutes: Up And Down Week Comes To A Close,2016-08-19 08:56:00-04:00,ILMN,neutral
660082.0,"Benzinga's M&A Chatter for Thursday August 18, 2016",2016-08-18 19:46:00-04:00,ILMN,neutral
660083.0,"Cowen & Co Doubts ILMN, TMO Merger Will Go Through, Says 'We Believe TMO/ILMN Is A Close To 0% Probability'",2016-08-18 12:08:00-04:00,ILMN,negative
660084.0,Benzinga's Volume Movers,2016-08-18 11:00:00-04:00,ILMN,neutral
660085.0,Illumina Shares Continue Higher; Traders Attributing to Unconfirmed Market Chatter of $30B Thermo Fisher Bid,2016-08-18 10:09:00-04:00,ILMN,positive
660086.0,Shares of Illumina at High of $175.22 Following Takeover Chatter,2016-08-18 10:05:00-04:00,ILMN,positive
660087.0,Rumor Traders Seem to be Targeting Pharma Stocks Today; Watch for Near-Term Parabolic Price Action in Illumina as Benzinga Has Learned of Anonymous Source Contacting Media Outlets Alleging Takeover Interest Surrounding Name,2016-08-17 14:35:00-04:00,ILMN,positive
660088.0,"Illumina Stock Shines Over The Past Quarter, Argus Raises Price Target",2016-08-08 18:13:00-04:00,ILMN,neutral
660089.0,PGDx Reports Collaboration Deal with Illumina for Development of Cancer In Vitro Diagnostic Test Kits,2016-08-08 07:36:00-04:00,ILMN,negative
660090.0,Illumina Names Apple's Philip W. Schiller to Board of Directors,2016-07-28 06:38:00-04:00,ILMN,neutral
660091.0,Illumina Sees Q3 Sales $625M-$630M vs $631.7M Est.,2016-07-26 16:09:00-04:00,ILMN,neutral
660092.0,Illumina Sees FY16 Adj. EPS $3.48-$3.58 vs $3.37 Est.,2016-07-26 16:08:00-04:00,ILMN,neutral
660093.0,"Illumina Reports Q2 Adj. EPS $0.86 vs $0.73 Est., Sales $600M vs $593M Est.",2016-07-26 16:05:00-04:00,ILMN,neutral
660094.0,Exact Sciences Spikes to High; Traders Attributing to Unconfirmed Chatter of Approach by Illumina,2016-07-12 12:43:00-04:00,ILMN,negative
660095.0,"Enzo Biochem's Life Sciences Unit Reaches $21 Million Patent Infringement Settlement in Delaware With Illumina, Inc.",2016-07-07 09:15:00-04:00,ILMN,negative
660096.0,"8-K from Enzo Biochem Shows Subsidiary, Enzo Life Sciences, Reached, Finalized Settlement Deal with Illumina, Includes $21M Payment to Co.",2016-07-07 08:07:00-04:00,ILMN,positive
660097.0,Morgan Stanley Sees Illumina Trading At Too High A Premium To Its Peers,2016-07-05 11:14:00-04:00,ILMN,neutral
660098.0,5 Largest Price Target Changes For Tuesday,2016-07-05 09:56:00-04:00,ILMN,neutral
660099.0,Benzinga's Top Downgrades,2016-07-05 09:08:00-04:00,ILMN,positive
660100.0,"The Market In 5 Minutes: More Bad News For The British Pound, Tesla And OKC Thunder",2016-07-05 08:45:00-04:00,ILMN,negative
660101.0,12 Stocks Moving In Tuesday's Pre-Market Session,2016-07-05 08:21:00-04:00,ILMN,neutral
660102.0,A Peek Into The Markets: U.S. Stock Futures Drop Ahead Of Factory-Orders Report,2016-07-05 07:49:00-04:00,ILMN,negative
660103.0,"Morgan Stanley Downgrades Illumina to Underweight, Downgrades PT to $110.00",2016-07-05 06:22:00-04:00,ILMN,neutral
660104.0,MolecularMD Enters Into a Collaboration Agreement With Illumina for Drug-Diagnostic Co-Development With Biopharma Drug Programs,2016-06-27 12:00:00-04:00,ILMN,positive
660105.0,Illumina Reports Initial Customer Orders for Global Screening Array: 3M+ Orders,2016-06-16 09:01:00-04:00,ILMN,neutral
660106.0,"Illumina VP of Products, Operations, Strategy Discussing Co. Spinoff Grail, Highlights Jeff Bezos, Bill Gates as Investors in Grail",2016-06-15 11:22:00-04:00,ILMN,neutral
660107.0,Illumina Slideshow Presentation from William Blair Growth Stock Conference Shows Expectation for Helix to Launch to Consumers in Late '16,2016-06-15 11:08:00-04:00,ILMN,positive
660108.0,"Illumina Shares Rally ~$1.40 Heading Into Pres, Incoming CEO's Presentation at William Blair Growth Stock Conference; Exec Currently Speaking at Conference",2016-06-15 11:07:00-04:00,ILMN,positive
660109.0,"What's The Single Best $10,000 Investment To Hold For The Next 25 Years?",2016-06-04 14:54:00-04:00,ILMN,positive
660110.0,"ArcherDX, Illumina Partner For Next-Gen Sequencing-Based In Vitro Diagnostic Development",2016-05-31 06:52:00-04:00,ILMN,neutral
660111.0,Short Interest Surges In Illumina And Vertex Pharmaceuticals,2016-05-13 13:26:00-04:00,ILMN,positive
660112.0,Goldman Adds Agilent To Conviction List: 'EPS Drivers Are Underappreciated',2016-05-11 08:48:00-04:00,ILMN,neutral
660113.0,12 Stocks Moving In Wednesday's Pre-Market Session,2016-05-04 08:32:00-04:00,ILMN,neutral
660114.0,12 Stocks You Should Be Watching Today,2016-05-04 05:11:00-04:00,ILMN,neutral
660115.0,"After-Hours Recap: Fast Food Earnings, Index Movers",2016-05-03 17:15:00-04:00,ILMN,neutral
660116.0,"Illumina Reports Q1 Adj. EPS $0.71 vs $0.74 Est., Sales $572M vs $596.3M Est.",2016-05-03 16:19:00-04:00,ILMN,neutral
660117.0,"Illumina Sees Q2 Adj. EPS $0.72-$0.74 vs $0.84 Est., Sales $590M-$594M vs $612.6M Est.",2016-05-03 16:18:00-04:00,ILMN,neutral
660118.0,"Illumina Sees FY16 Adj. EPS $3.35-$3.45 vs $3.49 Est., Sales Growth ~12%",2016-05-03 16:08:00-04:00,ILMN,positive
660119.0,"Earnings Scheduled For May 3, 2016",2016-05-03 04:02:00-04:00,ILMN,neutral
660120.0,"Pressure From Japan: Interest Rate Decision Weighs, But Earnings In Focus",2016-04-28 11:35:00-04:00,ILMN,positive
660121.0,Departure Of TrovaGene CCO Creates Near-Term Risks; Cantor Downgrades Stock,2016-04-25 16:53:00-04:00,ILMN,neutral
660122.0,"Citigroup Drops Illumina From Focus List, Adds Dish Networks",2016-04-25 16:33:00-04:00,ILMN,neutral
660123.0,Illumina Files Patent Infringement Suit in Switzerland against Genoma SA for Infringement of NIPT Patents,2016-04-21 16:38:00-04:00,ILMN,negative
660124.0,Vetr Top Raters Buying The Dip In Illumina,2016-04-20 15:19:00-04:00,ILMN,positive
660125.0,"Illumina Plummets 23%, Analysts Move To The Sidelines Amid Q1 Warning",2016-04-19 14:33:00-04:00,ILMN,negative
660126.0,Mid-Day Market Update: Badger Meter Rises Following Earnings Beat; Netflix Shares Drop,2016-04-19 12:17:00-04:00,ILMN,neutral
660127.0,"Cantor Downgrades Illumina, Is Waiting For This To Happen",2016-04-19 11:08:00-04:00,ILMN,neutral
660128.0,Mid-Morning Market Update: Markets Mostly Higher; Goldman Sachs Profit Beats Views,2016-04-19 09:53:00-04:00,ILMN,positive
660129.0,12 Stocks Moving In Tuesday's Pre-Market Session,2016-04-19 08:10:00-04:00,ILMN,neutral
660130.0,Illumina Falls 20% After Preliminary Q1 Results 'Fell Short Of Expectations',2016-04-19 07:54:00-04:00,ILMN,neutral
660131.0,"Cowen & Company Maintains Outperform on Illumina, Lowers PT to $180.00",2016-04-19 07:35:00-04:00,ILMN,negative
660132.0,"Leerink Swann Maintains Market Perform on Illumina, Lowers PT to $165.00",2016-04-19 07:35:00-04:00,ILMN,negative
660133.0,Cantor Fitzgerald Downgrades Illumina to Hold,2016-04-19 07:07:00-04:00,ILMN,neutral
660134.0,Bank of America Downgrades Illumina to Neutral,2016-04-19 06:35:00-04:00,ILMN,neutral
660135.0,"Morgan Stanley Maintains Equal-weight on Illumina, Lowers PT to $140.00",2016-04-19 04:44:00-04:00,ILMN,negative
660136.0,"Barclays Maintains Equal-weight on Illumina, Lowers PT to $160.00",2016-04-19 03:54:00-04:00,ILMN,negative
660137.0,Illumina Shares Plunge 22% Amid Concerning Outlook,2016-04-18 16:21:00-04:00,ILMN,positive
660138.0,"UPDATE: Illumina Highlights Q1 Results 'Fell Short of Expectations,' Cites 'largely due to lower than expected sales of HiSeq 2500, 3000 and 4000 instruments.'",2016-04-18 16:18:00-04:00,ILMN,negative
660139.0,Illumina Expects Q1 Revs $572M Vs Est $596.33M,2016-04-18 16:07:00-04:00,ILMN,neutral
660140.0,Illumina Announces $100 Million Investment In Venture Fund To 'Improve Human Health By Unlocking The Power Of The Genome',2016-04-15 08:46:00-04:00,ILMN,positive
660141.0,Illumina Will Invest $100M Over 10 Years in New Venture Fund,2016-04-14 16:18:00-04:00,ILMN,neutral
660142.0,"Illumina Shares Initiated With Buy, $175 Target At Argus",2016-03-30 09:26:00-04:00,ILMN,positive
660143.0,"Argus Research Initiates Coverage on Illumina at Buy, Announces $175.00 undefined",2016-03-30 05:53:00-04:00,ILMN,neutral
660144.0,"Barron's Picks And Pans: FedEx, Ilumina And More",2016-03-20 20:43:00-04:00,ILMN,neutral
660145.0,Barron's: The World's Best CEOs,2016-03-20 20:25:00-04:00,ILMN,positive
660146.0,"Illumina Shares Tick Lower After Hours; Co. Earlier Issued After-Hours Release Announcing Current Pres Francis deSouza to Assume CEO Role from Current Chair, CEO Jay Flately",2016-03-07 17:12:00-05:00,ILMN,neutral
660147.0,"The Stocks That Moved The S&P, Dow And Nasdaq Today",2016-03-07 16:32:00-05:00,ILMN,neutral
660148.0,Stocks To Watch During Cowen's 36th Annual Healthcare Conference,2016-03-01 13:21:00-05:00,ILMN,neutral
660149.0,Benzinga's Top Downgrades,2016-02-04 09:25:00-05:00,ILMN,positive
660150.0,"Canaccord Genuity Downgrades Illumina to Hold, Lowers to $160.00",2016-02-04 06:47:00-05:00,ILMN,negative
660151.0,10 Stocks Moving In Wednesday's Pre-Market Session,2016-02-03 08:24:00-05:00,ILMN,neutral
660152.0,Illumina Sees FY 2016 EPS $3.55-$3.65 Vs Est $3.64,2016-02-02 16:33:00-05:00,ILMN,neutral
660153.0,"Illumina Reports Q4 EPS $0.81 Vs Est $0.80, Sales $592M Vs Est $576.39M",2016-02-02 16:32:00-05:00,ILMN,neutral
660154.0,"Earnings Scheduled For February 2, 2016",2016-02-02 04:01:00-05:00,ILMN,neutral
660155.0,"8-K from Illumina Shows Co. CEO, Jay Flatley, Named Chair",2016-02-01 16:54:00-05:00,ILMN,neutral
660156.0,7 Biotech Traders Pick Their Favorite Stocks For 2016,2016-01-28 16:53:00-05:00,ILMN,positive
660157.0,Illumina Names Dr. Frances Arnold to Board of Directors,2016-01-28 06:33:00-05:00,ILMN,neutral
660158.0,Why Apple's Q1 Expectations And Contracting Multiple Don't Signal A Short-Term Comeback,2016-01-21 10:26:00-05:00,ILMN,neutral
660159.0,"Bio-Rad, Illumina To Co-Develop Comprehensive Solution For Single-Cell Genomics, Companies Expect To Launch Solution In Late 2016 or Early 2017",2016-01-11 14:32:00-05:00,ILMN,positive
660160.0,Illumina's Grail Announcement 'Underwhelmed' This Analyst,2016-01-11 14:09:00-05:00,ILMN,neutral
660161.0,Illumina Forms GRAIL to Enable Early Cancer Detection via Blood-Based Screening,2016-01-10 18:02:00-05:00,ILMN,negative
660162.0,Illumina Reports Filing of Two Patent Infringement Suits in Europe Related to NIPT,2016-01-07 16:09:00-05:00,ILMN,negative
660163.0,Illumina Shares Lower Amid Action From Multiple Sell-Side Analysts,2016-01-07 15:44:00-05:00,ILMN,neutral
660164.0,Wells Fargo Downgrades Illumina to Market Perform,2016-01-07 05:42:00-05:00,ILMN,positive
660165.0,"Avondale Partners Initiates Coverage on Illumina at Market Perform, Announces $175.00 PT",2016-01-06 18:06:00-05:00,ILMN,neutral
660166.0,Deutsche Bank Initiates Coverage on Illumina at Hold,2016-01-06 16:22:00-05:00,ILMN,neutral
660167.0,Illumina Spikes to High of $195.86,2015-12-29 12:42:00-05:00,ILMN,neutral
660168.0,bioMérieux and Illumina Report the Launch of bioMérieux EpiSeq Sequencing Service for Epidemiological Monitoring of Bacterial Infections,2015-12-14 16:01:00-05:00,ILMN,neutral
660169.0,"Novogene, Illumina Report Will Co-Develop NGS Diagnostic System for Reproductive Health, Oncology Applications",2015-12-14 11:44:00-05:00,ILMN,neutral
660170.0,More Wild Short Interest Swings In Biotech Stocks,2015-12-13 16:52:00-05:00,ILMN,positive
660171.0,Desktop Genetics Receives Strategic Investment from Illumina,2015-12-09 04:12:00-05:00,ILMN,neutral
660172.0,The Best Stock Ideas Of November,2015-12-01 16:38:00-05:00,ILMN,positive
660173.0,Benzinga's Volume Movers,2015-11-13 10:23:00-05:00,ILMN,neutral
660174.0,Morning Market Gainers,2015-11-13 09:42:00-05:00,ILMN,neutral
660175.0,Benzinga's Top #PreMarket Gainers,2015-11-13 08:14:00-05:00,ILMN,positive
660176.0,"Standard & Poors Announces Illumina to Join S&P 500, Replacing Sigma-Aldrich",2015-11-12 17:27:00-05:00,ILMN,positive
660177.0,Illumina Announces New $250M Share Repurchase Authorization,2015-11-02 06:32:00-05:00,ILMN,positive
660178.0,UPDATE: Illumina Updates FY15 Adj. EPS to $3.29-$3.31 vs $3.37 Est.,2015-10-20 16:09:00-04:00,ILMN,neutral
660179.0,"Illumina Sees Q4 Sales ~$570M vs $580M Est., Adj. EPS $0.78-$0.80 vs $0.87 Est.",2015-10-20 16:08:00-04:00,ILMN,neutral
660180.0,"Illumina Reports Q3 Adj. EPS $0.80 vs $0.79 Est., Sales $550M vs $556M Est.",2015-10-20 16:07:00-04:00,ILMN,neutral
660181.0,"Earnings Scheduled For October 20, 2015",2015-10-20 04:07:00-04:00,ILMN,neutral
660182.0,Option Alert: Oct $160 Put; 9118 Contracts @$7.90,2015-10-16 10:10:00-04:00,ILMN,positive
660183.0,Benzinga's Top Downgrades,2015-10-07 09:17:00-04:00,ILMN,positive
660184.0,Illumina Downgraded At Mizuho On Negative Pre-Announcement,2015-10-07 07:45:00-04:00,ILMN,negative
660185.0,Stocks Hitting 52-Week Lows,2015-10-06 10:18:00-04:00,ILMN,negative
660186.0,Morning Market Losers,2015-10-06 09:50:00-04:00,ILMN,negative
660187.0,Benzinga's Top Downgrades,2015-10-06 09:27:00-04:00,ILMN,positive
660188.0,Benzinga's Top #PreMarket Losers,2015-10-06 08:27:00-04:00,ILMN,negative
660189.0,"UPDATE: Mizuho's Criscuolo Downgrades Illumina Following Outlook, Says 'The weakness came from desktop instrument sales, in particular NextSeq'",2015-10-06 07:30:00-04:00,ILMN,negative
660190.0,Mizuho Securities Downgrades Illumina to Neutral,2015-10-06 07:28:00-04:00,ILMN,positive
660191.0,"Monday's After-Hours Movers Led By Du Pont, Arena Pharma, Illumina & Container Store Group",2015-10-05 17:26:00-04:00,ILMN,neutral
660192.0,UPDATE: Illumina FY15 Sales Growth Guidance Equates to Total Sales of ~$2.196B vs $2.25B Est.,2015-10-05 16:50:00-04:00,ILMN,positive
660193.0,Illumina Shares Down ~18% After Hours To $132.98,2015-10-05 16:08:00-04:00,ILMN,positive
660194.0,"UPDATE: Illumina Says 'Geographically, we were disappointed with instrument sales in Europe and continued weakness in the Asia-Pacific region'",2015-10-05 16:07:00-04:00,ILMN,negative
660195.0,UPDATE: Illumina Sees FY15 Sales Up 18%,2015-10-05 16:06:00-04:00,ILMN,neutral
660196.0,UPDATE: Illumina Sees Q4 Sales ~$570M vs $602.8M Est.,2015-10-05 16:06:00-04:00,ILMN,neutral
660197.0,UPDATE: Illumina Sees Q3 Sales $550M vs $568.6M Est.,2015-10-05 16:05:00-04:00,ILMN,neutral
660198.0,Illumina Reports Prelim. Q3 Sales,2015-10-05 16:05:00-04:00,ILMN,neutral
660199.0,"Pacific Biosciences Has 'Long Road' Ahead, But Cantor Still Bullish",2015-10-01 14:23:00-04:00,ILMN,neutral
660200.0,Morning Market Losers,2015-10-01 09:56:00-04:00,ILMN,negative
660201.0,Benzinga's Top Downgrades,2015-10-01 09:25:00-04:00,ILMN,positive
660202.0,"Leerink Warns Of Looming Uncertainty In Illumina, Downgrades",2015-10-01 09:08:00-04:00,ILMN,negative
660203.0,Benzinga's Top #PreMarket Losers,2015-10-01 08:31:00-04:00,ILMN,negative
660204.0,"UPDATE: Leerink Downgrades Illumina, Warns of Looming Uncertainty, Unclear of Next Catalyst in Research Market",2015-10-01 06:52:00-04:00,ILMN,negative
660205.0,"Leerink Swann Downgrades Illumina to Market Perform, Lowers PT to $185.00",2015-10-01 06:28:00-04:00,ILMN,negative
660206.0,"Illumina Still 'Top Growth' Play In Tools, DX Space",2015-09-30 09:37:00-04:00,ILMN,neutral
660207.0,"Stifel's Miroslava Minkova Sees Illumina as 'Still a Top Growth Opportunity in Tools & DX'; Maintains Buy Rating, $235 Price Target",2015-09-30 08:13:00-04:00,ILMN,positive
660208.0,"UBS Adds Dish Network To List Of Potential S&P 500 Index For The First Time, Notes 18 Companies Joined The Index This Year",2015-09-29 08:20:00-04:00,ILMN,neutral
660209.0,Illumina Announces Has Joined Worldwide Innovative Networking Consortium,2015-09-23 06:31:00-04:00,ILMN,positive
660210.0,Amgen And Biogen Lead Short Interest Surge In Biotechs,2015-09-14 16:01:00-04:00,ILMN,positive
660211.0,How Is Viking Global Beating The Market?,2015-09-03 12:13:00-04:00,ILMN,negative
660212.0,Benzinga's Top Initiations,2015-08-27 09:42:00-04:00,ILMN,positive
660213.0,"Cantor Fitzgerald Initiates Coverage on Illumina at Buy, Announces $265.00 PT",2015-08-27 07:38:00-04:00,ILMN,neutral
660214.0,Illumina Shares Added to Citi's 'Focus List',2015-08-26 06:49:00-04:00,ILMN,positive
660215.0,"Burning Rock, Illumina Announce Collaboration on Molecular Diagnostics for Oncology",2015-08-24 21:13:00-04:00,ILMN,neutral
660216.0,"In Case You Didn't Know: Brookdale Senior Living, Illumina Beat The S&P Last Week",2015-08-23 18:50:00-04:00,ILMN,neutral
660217.0,"Illumina Creates Helix: Here's What It Is, And What It's Worth",2015-08-19 09:44:00-04:00,ILMN,positive
660218.0,"Mizuho Securities Reinstates Buy on Illumina, Raises PT to $250.00",2015-08-19 04:46:00-04:00,ILMN,positive
660219.0,"Illumina, Warburg Pincus,  Sutter Hill Ventures Form Helix With $100M+ in Financing Commitments",2015-08-18 04:25:00-04:00,ILMN,positive
660220.0,Short Sellers Wary Of Biotech Stocks,2015-08-14 13:02:00-04:00,ILMN,neutral
660221.0,Credit Suisse: Top 11 Large-Cap Growth Stocks,2015-08-14 12:24:00-04:00,ILMN,positive
660222.0,Morning Market Losers,2015-07-22 09:58:00-04:00,ILMN,negative
660223.0,Benzinga's Top #PreMarket Losers,2015-07-22 08:28:00-04:00,ILMN,negative
660224.0,Janney Capital Downgrades Illumina to Neutral,2015-07-22 07:59:00-04:00,ILMN,neutral
660225.0,"Earnings Scheduled For July 21, 2015",2015-07-21 04:01:00-04:00,ILMN,neutral
660226.0,"Wedbush Hikes Illumina Target To $250, Feeling Good About 2016",2015-07-14 08:57:00-04:00,ILMN,positive
660227.0,"Study of Illumina's Non-Invasive verifi Prenatal Test Suggests that Test Results, When Discordant from Fetal Karyotyping, May Reflect Presence of Maternal Cancer",2015-07-13 16:05:00-04:00,ILMN,negative
660228.0,"Neogen, Illumina Sign Commercialization Agreement; Terms Not Disclosed",2015-07-07 08:45:00-04:00,ILMN,positive
660229.0,"Illumina PT Raised At Cowen To $300 From $264, Cowen Cites Increased Confidence In 20%+ Y/Y Rev Growth & Continued Upside To Margin Expectations",2015-07-01 09:36:00-04:00,ILMN,positive
660230.0,Biotech Short-Sellers Prefer Amgen To Gilead Sciences,2015-06-27 18:02:00-04:00,ILMN,neutral
660231.0,"Annoroad, Illumina to Co-Develop NGS Diagnostic System for Reproductive Health",2015-06-10 04:02:00-04:00,ILMN,neutral
660232.0,Benzinga's Top Upgrades,2015-05-21 09:27:00-04:00,ILMN,positive
660233.0,Morgan Stanley Upgrades Illumina To Overweight,2015-05-21 09:03:00-04:00,ILMN,negative
660234.0,"Morgan Stanley Upgrades Illumina to Overweight, Lowers PT to $162.00",2015-05-21 06:21:00-04:00,ILMN,negative
660235.0,"Illumina Announces Filing of New Patent Infringement Suit Against Ariosa Diagnostics, Roche Molecular Systems",2015-05-18 16:11:00-04:00,ILMN,negative
660236.0,"Viking Global Liked AIG, Google, Actavis, Illumina And Cheniere Energy Last Quarter",2015-05-18 13:38:00-04:00,ILMN,positive
660237.0,3 Biotech Stocks See Growing Short Interest,2015-05-13 09:40:00-04:00,ILMN,positive
660238.0,"After-Hours Movers Wednesday: Whole Foods Market Inc., Keurig Green Mountain Inc.",2015-05-06 17:39:00-04:00,ILMN,neutral
660239.0,Tigress Financial Upgrades Illumina to Strong Buy,2015-04-23 10:56:00-04:00,ILMN,positive
660240.0,"Yum! Brands, Chipotle, United Rentals Lead Tuesday's After-Hours Movers",2015-04-21 18:44:00-04:00,ILMN,positive
660241.0,"Illumina Reports Q1 Adj. EPS $0.91 vs $0.70 Est., Sales $538.6M vs $524M Est.; Raises FY Adj. EPS Outlook from $3.12-$3.18 to $3.36-$3.42 vs $3.20 Est.",2015-04-21 16:07:00-04:00,ILMN,neutral
660242.0,"Earnings Scheduled For April 21, 2015",2015-04-21 03:58:00-04:00,ILMN,neutral
660243.0,Illumina May 195 Call; 1537 Contracts Traded vs 54 OI; Now $192.45,2015-04-16 11:32:00-04:00,ILMN,neutral
660244.0,3 Biotech Stocks Bucking Short Interest Trends,2015-03-26 15:35:00-04:00,ILMN,positive
660245.0,Is It Closing Time At The Biotech Bar?,2015-03-26 13:45:00-04:00,ILMN,neutral
660246.0,Illumina Files Patent Infringement Suit in UK vs Premaitha Health for Infringement of NIPT Patents,2015-03-16 04:38:00-04:00,ILMN,negative
660247.0,Illumina Announces Strategic Collaboration with Merck Serono,2015-03-10 09:08:00-04:00,ILMN,neutral
660248.0,UBS Initiates Coverage on Illumina at Buy,2015-03-10 04:45:00-04:00,ILMN,neutral
660249.0,3 Niche ETFs Breaking Out,2015-02-17 14:42:00-05:00,ILMN,neutral
660250.0,Wedbush Securities Raises Price Target On Illumina On Higher Quality 4Q14 Results,2015-01-28 10:13:00-05:00,ILMN,positive
660251.0,"Illumina Shares Up Nearly 2% Following Better-Than-Expected Q4 Results: Adj. EPS $0.87 vs $0.78 Est, Sales $512M vs $507.7M",2015-01-27 17:14:00-05:00,ILMN,positive
660252.0,"Earnings Scheduled For January 27, 2015",2015-01-27 04:34:00-05:00,ILMN,neutral
660253.0,Illumina Announces Launch of MiSeq FGx Forensic Genomics System,2015-01-21 06:36:00-05:00,ILMN,neutral
660254.0,"Lockheed Martin, Illumina Form Collaboration",2015-01-12 14:44:00-05:00,ILMN,neutral
660255.0,Illumina Sees Adjusted FY2015 EPS $3.12-3.18 vs $3.17 Est,2015-01-12 14:37:00-05:00,ILMN,neutral
660256.0,From JPMorgan Conference: Illumina Sees Preliminary 2014 Adjusted EPS $2.63-$2.65 vs $2.64 Est.,2015-01-12 14:28:00-05:00,ILMN,neutral
660257.0,Illumina Reports Preliminary 4Q Revenue $512M vs $504.1M Est,2015-01-12 14:22:00-05:00,ILMN,negative
660258.0,"Illumina Shares Initially Spike Higher, then Gap Down",2015-01-12 14:19:00-05:00,ILMN,positive
660259.0,Universities of Edinburgh and Glasgow to Partner with Illumina on £15M Project,2015-01-11 19:31:00-05:00,ILMN,neutral
660260.0,"Barclays Initiates Coverage On Life Science Tools & Diagnostics, Names Thermo Fisher As 'Top Pick'",2015-01-07 16:41:00-05:00,ILMN,positive
660261.0,Hedge Funds And Alibaba: Who's Been Bullish?,2014-12-26 08:49:00-05:00,ILMN,neutral
660262.0,Is Illumina Worth Adding To Your Portfolio?,2014-12-17 08:34:00-05:00,ILMN,positive
660263.0,Mid-Day Market Update: U.S. Stocks Edge Higher; G-III Apparel Shares Jump On Upbeat Results,2014-12-03 12:45:00-05:00,ILMN,positive
660264.0,Mid-Morning Market Update: Markets Mixed; Abercrombie & Fitch Lowers Earnings Guidance,2014-12-03 10:42:00-05:00,ILMN,negative
660265.0,Morning Market Movers,2014-12-03 09:50:00-05:00,ILMN,neutral
660266.0,Benzinga's Top #PreMarket Gainers,2014-12-03 08:13:00-05:00,ILMN,positive
660267.0,"Sequenom Shares Rise 23% Premarket on Settlement of Patent Disputes with Illumina, Agreement to Pool Noninvasive Prenatal Testing IP",2014-12-03 08:12:00-05:00,ILMN,positive
660268.0,"Illumina, Sequenom Pool Noninvasive Prenatal Testing Intellectual Property; End Outstanding Patent Disputes",2014-12-03 06:04:00-05:00,ILMN,positive
660269.0,"bioMérieux, Illumina Enter Agreement to Co-Develop NGS EpidemiologyS olution for Service Labs",2014-11-18 05:00:00-05:00,ILMN,positive
660270.0,Sequenta Enters Agreement with Illumina,2014-11-17 09:04:00-05:00,ILMN,positive
660271.0,Meet The 5 Companies Loving Obamacare,2014-11-04 20:04:00-05:00,ILMN,positive
660272.0,HTG Announces Supply Agreement With Illumina ,2014-10-30 07:10:00-04:00,ILMN,positive
660273.0,Illumina's Break Could Be Investor's Gain,2014-10-29 15:00:00-04:00,ILMN,positive
660275.0,Markets Surge; McDonald's Posts Lower Sales,2014-10-21 10:38:00-04:00,ILMN,negative
660276.0,Benzinga's Top Upgrades,2014-10-21 10:28:00-04:00,ILMN,positive
660277.0,Janney Capital Upgrades Illumina To Buy,2014-10-21 10:10:00-04:00,ILMN,neutral
660278.0,"Janney Capital Upgrades Illumina, Inc. to Buy, Raises PT to $192.00",2014-10-21 09:25:00-04:00,ILMN,neutral
660279.0,Benzinga's Top #PreMarket Gainers,2014-10-21 08:14:00-04:00,ILMN,positive
660280.0,Illumina Spikes 10% On Q3 Earnings Beat,2014-10-20 17:17:00-04:00,ILMN,neutral
660281.0,"Illumina, Inc. Raises FY2014 EPS Guidance from $2.26-2.28 to $2.63-2.65 vs $2.30 Est",2014-10-20 16:06:00-04:00,ILMN,neutral
660282.0,"Illumina, Inc. Reports Q3 EPS of $0.77 vs $0.56 Est; Revenue of $481.0M vs $451.20M Est.  Raising Outlook",2014-10-20 16:05:00-04:00,ILMN,neutral
660283.0,"Earnings Scheduled For October 20, 2014",2014-10-20 05:26:00-04:00,ILMN,neutral
660284.0,Illumina Launches New Reagent Kits For HiSeq X Ten And HiSeq 2500 Systems,2014-10-17 06:34:00-04:00,ILMN,neutral
660285.0,Benzinga's Top Upgrades,2014-10-16 09:16:00-04:00,ILMN,positive
660286.0,Piper Jaffray Upgrades Illumina To Overweight,2014-10-16 07:54:00-04:00,ILMN,negative
660287.0,"Piper Jaffray Upgrades Illumina, Inc. to Overweight, Up PT to $192.00",2014-10-16 05:52:00-04:00,ILMN,negative
660288.0,Big Swings in Biotech Short Interest,2014-10-13 08:32:00-04:00,ILMN,positive
660289.0,"UPDATE: BTIG Research Initiates Coverage On Illumina, Inc. On Long-Term Investment Opportunity",2014-10-03 07:59:00-04:00,ILMN,positive
660290.0,"BTIG Research Initiates Coverage on Illumina, Inc. at Buy",2014-10-02 16:47:00-04:00,ILMN,neutral
660291.0,Shares of Illumina Remain in Negative Territory Despite Being Added to Tigress Financial's 'Focus List' in Mid-Day Research Note,2014-10-02 10:54:00-04:00,ILMN,negative
660292.0,"Morgan Stanley Initiates Coverage on Illumina, Inc. at Equal-weight, Announces $190.00 PT",2014-09-08 06:02:00-04:00,ILMN,neutral
660293.0,The 4 Companies Teaming Up For A New Tool To Fight Cancer,2014-08-25 16:03:00-04:00,ILMN,negative
660294.0,US Stock Futures Surge Ahead Of Economic Data,2014-08-21 07:26:00-04:00,ILMN,neutral
660295.0,"Illumina Announces Strategic Partnerships with AstraZeneca, Janssen, Sanofi",2014-08-21 05:21:00-04:00,ILMN,neutral
660296.0,Markets Mostly Higher Despite Initial Negative Reaction From FOMC Minutes,2014-08-20 17:31:00-04:00,ILMN,positive
660297.0,"Wedbush Upgrades Illumina To Outperform, Shares Rise",2014-08-20 10:57:00-04:00,ILMN,positive
660298.0,"Wedbush Upgrades Illumina, Inc. to Outperform, Raises PT to $200.00",2014-08-20 09:22:00-04:00,ILMN,neutral
660299.0,Markets Marginally Lower In Quiet Trading Session,2014-08-12 16:40:00-04:00,ILMN,negative
660300.0,"UPDATE: Stifel Nicolaus Initiates Coverage on Illumina, Inc. at Buy, Announces $200.00 PT",2014-08-12 11:36:00-04:00,ILMN,neutral
660301.0,Benzinga's Top Initiations ,2014-08-12 09:18:00-04:00,ILMN,positive
660302.0,Stifel Nicolaus Initiates Illumina At Buy,2014-08-12 08:09:00-04:00,ILMN,neutral
660303.0,"Stifel Nicolaus Initiates Coverage on Illumina, Inc. at Buy, Announces $200.00 PT",2014-08-12 06:36:00-04:00,ILMN,neutral
660304.0,UPDATE: Tigress Initiates Coverage On Illumina,2014-08-01 15:14:00-04:00,ILMN,neutral
660305.0,"Tigress Financial Initiates Coverage on Illumina, Inc. at Buy",2014-08-01 14:11:00-04:00,ILMN,neutral
660306.0,"Illumina, Inc. Up ~2.14% ",2014-07-23 16:23:00-04:00,ILMN,neutral
660307.0,"Illumina, Inc. Raises FY2014 EPS Guidance from $2.10-2.15 to $2.26-2.28 vs $2.17 Est, Sales Growth 25-26% Range",2014-07-23 16:11:00-04:00,ILMN,positive
660308.0,Illumina Reports Q2 Adj. EPS $0.57,2014-07-23 16:08:00-04:00,ILMN,neutral
660309.0,"Illumina, Inc. Reports Q2 EPS of $0.31 vs $0.51 Est; Revenue of $447.60 vs $426.98M Est",2014-07-23 16:06:00-04:00,ILMN,neutral
660310.0,"Illumina, Inc. Reports Q2 EPS of $0.31 Which May Not Compare $0.51 Est; Revenue of $447.60 Which May Not Compare $426.98M Est",2014-07-23 16:06:00-04:00,ILMN,neutral
660311.0,"Berry Genomics, Illumina Co-Develop Integrated Next-Generation Sequencing System for Review and Approval by Chinese FDA",2014-07-21 06:37:00-04:00,ILMN,positive
660312.0,Earnings Continue Driving Markets Higher,2014-07-16 17:23:00-04:00,ILMN,neutral
660313.0,Illumina Names Tina S. Nova As Senior Vice Pres And General Manager Of Oncology,2014-07-14 16:08:00-04:00,ILMN,neutral
660314.0,3 Hot Biotech Stocks Hitting Highs,2014-06-23 14:00:00-04:00,ILMN,neutral
660315.0,Seeing Insider Selling in Illumina,2014-06-17 13:48:00-04:00,ILMN,neutral
660316.0,Five Star Biotech Stock Watch: Illumina,2014-06-04 13:46:00-04:00,ILMN,neutral
660317.0,Illumina Launches VeriSeq PGS ,2014-04-29 06:47:00-04:00,ILMN,neutral
660318.0,Illumina Reports Filing of New Patent Infringement Case Against Ariosa Diagnostics,2014-04-25 16:10:00-04:00,ILMN,negative
660319.0,"Maxim Group Upgrades Illumina, Inc. to Buy, Announces $205.00 PT",2014-04-23 08:40:00-04:00,ILMN,neutral
660320.0,"Bank of America Maintains Buy on Illumina, Inc., Raises PT to $195.00",2014-04-23 07:18:00-04:00,ILMN,neutral
660321.0,"Illumina, Inc. Reports Q1 EPS of $0.53 vs $0.45 Est; Revenue of $421.0M vs $391.50M Est",2014-04-22 16:05:00-04:00,ILMN,neutral
660322.0,"Illumina to Announce Q1 2014 Financial Results on Tuesday, April 22, 2014 After the Market Close",2014-04-07 06:31:00-04:00,ILMN,neutral
660323.0,"Macquarie Upgrades Illumina, Inc. to Outperform",2014-04-02 08:42:00-04:00,ILMN,neutral
660324.0,Illumina Announces New Products to Support Oncology Clinical Research and Discovery ,2014-04-02 06:33:00-04:00,ILMN,positive
660325.0,WuXi PharmaTech Acquires Illumina HiSeq X Ten Sequencing System ,2014-03-10 06:33:00-04:00,ILMN,neutral
660326.0,Market Wrap For March 5: Markets Calm Following Tuesday's Massive Rally,2014-03-05 16:40:00-05:00,ILMN,positive
660327.0,Illumina Announces Non-Invasive verifi Prenatal Test Using cfDNA Significantly Reduces False Positive Rate of Fetal Aneuploidy Detection Compared to Current Standard Pregnancy Screening Practices,2014-02-26 17:01:00-05:00,ILMN,positive
660328.0,Novogene Acquires Illumina HiSeq X Ten Sequencing System ,2014-02-13 06:42:00-05:00,ILMN,neutral
660329.0,Illumina Launches World's First Genomics Incubator ,2014-02-12 06:42:00-05:00,ILMN,neutral
660330.0,"Form 8-K from Illumina Shows Francis DeSouza Named to Board, Board Size Increased from Nine to Ten",2014-02-05 09:03:00-05:00,ILMN,positive
660331.0,Illumina Announces $250M Buyback Plan,2014-02-03 16:34:00-05:00,ILMN,neutral
660332.0,"Illumina, Inc. Reports Q4 EPS of $0.45 vs $0.44 Est; Revenue of $387.0M vs $382.06M Est",2014-01-28 16:05:00-05:00,ILMN,neutral
660333.0,Illumina Signs Master Supply Agreement with LabCorp,2014-01-21 06:32:00-05:00,ILMN,positive
660334.0,Market Wrap For January 17: Stocks Finish Week With Mixed Results,2014-01-17 16:40:00-05:00,ILMN,neutral
660335.0,US Stock Futures Surge Ahead Of Morgan Stanley Earnings,2014-01-17 07:06:00-05:00,ILMN,neutral
660336.0,Illumina Announces New Organizational Alignment -8K,2014-01-17 05:43:00-05:00,ILMN,neutral
660337.0,Market Wrap For January 16: Markets End Two Day Winning Streak,2014-01-16 16:46:00-05:00,ILMN,positive
660338.0,"Illumina Exec Currently Speaking at Co.'s Investor Meeting, Says Expecting Tremendous Interest in HISEQ X Machines",2014-01-16 16:29:00-05:00,ILMN,positive
660339.0,"Amgen, Illumina Announce Deal to Develop Oncology Companion Diagnostic Test",2014-01-15 16:05:00-05:00,ILMN,neutral
660340.0,"Illumina, Inc. Sees FY2014 EPS $2.00-2.06 vs $2.05 Est",2014-01-14 11:36:00-05:00,ILMN,neutral
660341.0,"Illumina, Inc. Sees Q4 Sales $387.0M vs $369.50M Est, Sees Slightly Above Top End of Range",2014-01-14 11:36:00-05:00,ILMN,positive
660342.0,Amended 13G Filing from Baillie Gifford & Co. on Illumina Shows Lowered Stake from 12.61% as of Sept. 30th to 12.09% Stake,2014-01-10 11:18:00-05:00,ILMN,negative
660343.0,UPDATE: JMP Securities Initiates Coverage on Illumina on Multiple Positive Factors,2013-12-18 10:17:00-05:00,ILMN,positive
660344.0,Benzinga's Top Initiations,2013-12-18 08:19:00-05:00,ILMN,positive
660345.0,"JMP Securities Initiates Coverage on Illumina, Inc. at Market Outperform, Announces $125.00 PT",2013-12-18 06:54:00-05:00,ILMN,positive
660346.0,"Bank of America Maintains Buy on Illumina, Inc., Raises PO to $112.00",2013-12-12 06:36:00-05:00,ILMN,negative
660347.0,Illumina Receives FDA Premarket Clearance for MiSeqDx System,2013-11-19 18:44:00-05:00,ILMN,neutral
660348.0,FDA Okays Four Next Gen Gene Sequencing Devices Manufactured by Illumina,2013-11-19 17:36:00-05:00,ILMN,positive
660349.0,Gilead Sciences Leads In Rising Short Interest Among Biotechs ,2013-11-12 16:41:00-05:00,ILMN,positive
660350.0,Illumina Names Francis Desouza President,2013-11-11 16:13:00-05:00,ILMN,neutral
660351.0,Illumina Appoints Francis deSouza as President ,2013-11-11 16:10:00-05:00,ILMN,neutral
660352.0,Syntrix Biosystems Announces Court Upholds $115M Patent Infringement Judgement Against Illumina,2013-11-06 13:23:00-05:00,ILMN,negative
660353.0,"Illumina Signs Agreement to Acquire NextBio, Leader in Analyzing and Aggregating Complex Genomic Data ",2013-10-28 08:02:00-04:00,ILMN,positive
660354.0,"Short Sellers Retreat From Biogen Idec, Move On Pharmacyclics (BIIB, BMRN, PCYC)",2013-10-25 15:36:00-04:00,ILMN,positive
660355.0,"Form 8-K from Illumina Shows Enhancement for Hiseq Family, to Be Capable of Up to 4B Clusters in Six Days",2013-10-23 12:53:00-04:00,ILMN,positive
660356.0,Illumina Announces TruGenome Undiagnosed Disease Test ,2013-10-22 06:41:00-04:00,ILMN,neutral
660357.0,"Illumina, Inc. Raises FY2013 EPS Guidance from $1.68-1.72 to $1.75-1.77 vs $1.72 Est",2013-10-21 16:10:00-04:00,ILMN,neutral
660358.0,"Illumina, Inc. Reports Q3 EPS of $0.45 vs $0.40 Est; Revenue of $356.80M vs $343.56M Est",2013-10-21 16:06:00-04:00,ILMN,neutral
660359.0,"Earnings Scheduled For October 21, 2013",2013-10-21 06:39:00-04:00,ILMN,neutral
660360.0,"Illumina Collaborates with University of Cambridge, Genomics England",2013-10-21 06:06:00-04:00,ILMN,neutral
660361.0,"UPDATE: Illumina Will Be Consolidating Commercial Organization, Channel",2013-10-16 08:03:00-04:00,ILMN,neutral
660362.0,"Form 8-K from Illumina Shows Co. Realigning Units, Will Add Role of President",2013-10-16 08:03:00-04:00,ILMN,neutral
660363.0,Illumina's Verinata Health Reports Expanded Test of Verifi for Option to Test for Fetal Aneuploidy in Twin Pregnancies,2013-10-14 06:36:00-04:00,ILMN,neutral
660364.0,"Short Sellers Move On Amgen, Vertex (AMGN, PCYC, VRTX)",2013-10-11 14:33:00-04:00,ILMN,neutral
660365.0,"BioMarin, Celgene Lead Trend in Biotech Short Interest (BRMN, CELG, REGN)",2013-09-25 12:52:00-04:00,ILMN,positive
660366.0,Illumina Applies CE Mark to Expanded MiSeqDx™ System ,2013-09-25 06:34:00-04:00,ILMN,neutral
660367.0,Illumina's Verinata Reports Non-invasive Verifi Prenatal Test2 Ccorrectly Detects Aneuploidies Across All Test Samples,2013-09-19 06:41:00-04:00,ILMN,neutral
660368.0,"Alexion, Pharmacyclics Buck Trend in Biotech Short Interest (ALXN, CELG, PCYC)",2013-09-14 11:47:00-04:00,ILMN,positive
660369.0,UPDATE: Wells Fargo Initiates Coverage on Illumina on Prime Market Position,2013-09-10 09:35:00-04:00,ILMN,positive
660370.0,"Wells Fargo Initiates Coverage on Illumina, Inc. at Outperform",2013-09-09 17:55:00-04:00,ILMN,positive
660371.0,"Sony and Illumina Set to Change the Way Doctors Identify and Treat Cancer (ILMN, SNE)",2013-09-05 14:55:00-04:00,ILMN,negative
660372.0,"Illumina to Supply Natera with Sequencing Instruments, Consumables for NIPT",2013-09-04 06:34:00-04:00,ILMN,neutral
660373.0,"Short Interest In Celgene, Onyx Continues To Shrink (CELG, ONXX, VRTX)",2013-08-27 13:29:00-04:00,ILMN,positive
660374.0,"Sony, Illumina in Human Genome Analysis Service JV - Nikkei",2013-08-27 13:11:00-04:00,ILMN,neutral
660375.0,"Janney Capital Initiates Coverage on Illumina, Inc. at Neutral, Announces $86.00 PT",2013-08-15 08:52:00-04:00,ILMN,neutral
660376.0,"Benzinga's M&A Chatter for Monday August 12, 2013",2013-08-12 18:02:00-04:00,ILMN,neutral
660377.0,Illumina's Verinata Health Receives New York State Laboratory Permit for verifi Prenatal Test ,2013-08-01 20:18:00-04:00,ILMN,neutral
660378.0,"Short Interest in Pharmacyclics Plunges (AMGN, ONXX, PCYC)",2013-07-26 10:46:00-04:00,ILMN,positive
660379.0,"Market Wrap for Wednesday, July 24: Stocks Largely Lower Despite Jump in New Home Sales",2013-07-24 16:13:00-04:00,ILMN,negative
660380.0,"Credit Suisse Maintains Outperform on Illumina, Inc., Raises PT to $84.00",2013-07-24 07:57:00-04:00,ILMN,positive
660381.0,"Benzinga's M&A Chatter for Tuesday July 23, 2013",2013-07-23 17:58:00-04:00,ILMN,neutral
660382.0,"Illumina, Inc. Reports Q2 EPS of $0.43 vs $0.40 Est; Revenue of $346.0M vs $331.77M Est",2013-07-23 16:13:00-04:00,ILMN,neutral
660383.0,"Illumina Raises FY13 Outlook, Now Expecting Growth 20%",2013-07-23 16:12:00-04:00,ILMN,positive
660384.0,"Illumina Acquires Advanced Liquid Logic, Leader in Digital Microfluidics Solutions ",2013-07-23 16:02:00-04:00,ILMN,positive
660385.0,Illumina Agrees to Dismiss All Claims Against Complete Genomics,2013-07-18 14:09:00-04:00,ILMN,positive
660386.0,Illumina Announces Phasing Analysis Service ,2013-07-18 06:50:00-04:00,ILMN,neutral
660387.0,Illumina Spikes Higher,2013-07-12 10:13:00-04:00,ILMN,neutral
660388.0,"Short Interest Rises in Gilead Sciences, Onyx Pharmaceuticals (BIIB, GILD, ONXX)",2013-07-11 12:47:00-04:00,ILMN,positive
660389.0,UPDATE: Piper Jaffray Downgrades Illumina to Neutral on Tough 2H13 Comps,2013-07-02 13:02:00-04:00,ILMN,negative
660390.0,Benzinga's Top Downgrades,2013-07-02 07:35:00-04:00,ILMN,positive
660391.0,A Peek Into The Market Before The Trading Starts,2013-07-02 07:26:00-04:00,ILMN,neutral
660392.0,"Piper Jaffray Downgrades Illumina, Inc. to Neutral, Lowers PT to $70.00",2013-07-02 06:41:00-04:00,ILMN,negative
660393.0,A Peek Into The Market Before The Trading Starts,2013-07-01 07:20:00-04:00,ILMN,neutral
660394.0,Illumina's Verinata Health Signs Agreement with Teva Pharmaceutical,2013-07-01 06:33:00-04:00,ILMN,positive
660395.0,Illumina Applies CE Mark to MiSeqDx Cystic Fibrosis System ,2013-07-01 06:31:00-04:00,ILMN,neutral
660396.0,UPDATE: Goldman Sachs Raises PT on Illumina on BaseSpace Thoughts,2013-06-27 09:44:00-04:00,ILMN,neutral
660397.0,"Short Interest in Biogen Idec and Vertex Shrinks (BIIB, CELG, VRTX)",2013-06-26 13:17:00-04:00,ILMN,positive
660398.0,"Short Interest Falls in Vertex, Rises in Biogen Idec (VRTX, BIIB)",2013-06-12 13:29:00-04:00,ILMN,positive
660399.0,"Short Interest in Vertex Rises, in Biogen Idec Falls",2013-05-29 13:19:00-04:00,ILMN,positive
660400.0,"Illumina Exec Speaking at UBS Healthcare Conference, Says Verinata Reimbursement Exceeding Expectations",2013-05-20 11:50:00-04:00,ILMN,neutral
660401.0,"Illumina, Inc. Affirms FY2013 EPS Guidance of $1.55-1.62 vs $1.67 Est",2013-05-16 07:36:00-04:00,ILMN,neutral
660402.0,Dan Loeb's Third Point Liquidated its 1.5M Share Stake in Illumina,2013-05-15 16:34:00-04:00,ILMN,positive
660403.0,"Loeb's Third Point Sold Out of Illumina, Herbalife, Morgan Stanley, Symantec",2013-05-15 16:20:00-04:00,ILMN,neutral
660404.0,UPDATE: Bank of America Raises PO on Illumina on New Product Rollouts,2013-05-15 10:54:00-04:00,ILMN,negative
660405.0,"Bank of America Maintains Buy on Illumina, Inc., Raises PO to $77.00",2013-05-15 07:49:00-04:00,ILMN,negative
660406.0,A Peek Into The Market Before The Trading Starts,2013-05-15 07:35:00-04:00,ILMN,neutral
660407.0,Illumina Announces Collaborations to Automate TruSeq and Nextera Sample Preparation Kits ,2013-05-15 06:37:00-04:00,ILMN,neutral
660408.0,"Benzinga's M&A Chatter for Friday May 10, 2013",2013-05-11 10:51:00-04:00,ILMN,neutral
660409.0,"Short Interest in Vertex Rises, in Celgene Falls",2013-05-11 10:45:00-04:00,ILMN,positive
660410.0,Roche Says Illumina Deal Off the Table,2013-05-10 15:58:00-04:00,ILMN,neutral
660411.0,Roche Declines Comment on Bid for Ilumina,2013-05-10 15:31:00-04:00,ILMN,neutral
660412.0,Illumina Declines Comment on Roche Bid Rumor,2013-05-10 15:30:00-04:00,ILMN,neutral
660413.0,Hearing Additional Chatter on Illumina that $88 Bid May Not Be Leigitimate,2013-05-10 15:22:00-04:00,ILMN,neutral
660414.0,Swiss Publication L'Agefi Says Roche Makes $88/Share Bid for Illumina,2013-05-10 14:59:00-04:00,ILMN,neutral
660415.0,Illumina and Other Bargain Biotech Stocks Worth a Look Now,2013-05-01 12:57:00-04:00,ILMN,positive
660416.0,"Short Sellers Move into Celgene, Regeneron",2013-04-26 13:25:00-04:00,ILMN,neutral
660417.0,"UBS O'Connor Held 400,000 Share Ilumina Stake as of March 31st -Bloomberg",2013-04-24 13:46:00-04:00,ILMN,positive
660418.0,"Market Wrap for Tuesday, April 23: Major Averges Climb Better Than 1% Despite Mini Flash-Crash",2013-04-23 16:31:00-04:00,ILMN,positive
660419.0,Mid-Afternoon Market Update: Hacked AP Twitter Account Causes Flash Crash,2013-04-23 15:24:00-04:00,ILMN,negative
660420.0,"Mid-Day Market Update: II-VI Declines On Weak Results, Netflix Spikes Higher",2013-04-23 12:54:00-04:00,ILMN,negative
660421.0,UPDATE: Credit Suisse Raises PT on Illumina on Great 1Q 2013 Results,2013-04-23 11:11:00-04:00,ILMN,positive
660422.0,Stocks Hitting 52-Week Highs,2013-04-23 10:18:00-04:00,ILMN,neutral
660423.0,"Credit Suisse Maintains Outperform on Illumina, Inc., Raises PT to $72.00",2013-04-23 08:09:00-04:00,ILMN,positive
660424.0,"From Illumina Call: Says Has Not Been Affected by Sequester Issues, Says Not Updating Guidance at This Time",2013-04-22 17:26:00-04:00,ILMN,positive
660425.0,"Illumina, Inc. Reports Q1 EPS of $0.46 vs $0.39 Est; Revenue of $331.0M vs $310.64M Est",2013-04-22 16:05:00-04:00,ILMN,neutral
660426.0,"Earnings Scheduled For April 22, 2013",2013-04-22 05:02:00-04:00,ILMN,neutral
660427.0,A Peek Into The Market Before The Trading Starts,2013-04-18 07:44:00-04:00,ILMN,neutral
660428.0,"Illumina, Kindstar in Strategic Collaboration",2013-04-18 06:35:00-04:00,ILMN,neutral
660429.0,"Short Sellers Move Out of Amgen, Celgene, Pharmacyclics",2013-04-10 13:30:00-04:00,ILMN,neutral
660430.0,"Short Sellers Dump Amgen, Focus on Celgene, Gilead Sciences",2013-03-28 08:18:00-04:00,ILMN,negative
660431.0,"Illumina Entered in Amended Right Agreement, Changes Final Expiration Date to Mar. 27th",2013-03-28 08:03:00-04:00,ILMN,positive
660432.0,Illumina Announces Favorable Outcome of Its Patent Litigation Against Life Technologies,2013-03-21 16:29:00-04:00,ILMN,positive
660433.0,Illumina Reports Favorable Outcome of Patent Litigation vs Life,2013-03-21 16:29:00-04:00,ILMN,positive
660434.0,Illumina Responds to Patent Infringement Ruling,2013-03-14 22:04:00-04:00,ILMN,negative
660435.0,"Short Interest Swings in Biotech Stocks (AMGN, CELG, PCYC)",2013-03-12 13:19:00-04:00,ILMN,positive
660436.0,"UBS Upgrades Illumina, Inc. to Buy",2013-03-01 08:09:00-05:00,ILMN,neutral
660437.0,"Short Interest Swings in Biotech Stocks (ALXN, AMGN, CELG)",2013-02-28 15:13:00-05:00,ILMN,positive
660438.0,Illumina Spikes Higher on Volume,2013-02-19 11:37:00-05:00,ILMN,neutral
660439.0,"Short Interest Swings in Biotech Stocks (AMGN, CELG, ONXX)",2013-02-12 13:29:00-05:00,ILMN,positive
660440.0,"Cantor Fitzgerald Maintains Hold on Illumina, Inc., Raises PT to $48.00",2013-01-29 13:23:00-05:00,ILMN,neutral
660441.0,"ISI Group Maintains Neutral on Illumina, Inc., Raises PT to $55.00",2013-01-29 08:38:00-05:00,ILMN,neutral
660442.0,"First Analysis Downgrades Illumina, Inc. to Equal-weight, Maintains $51.00 PT",2013-01-29 08:16:00-05:00,ILMN,neutral
660443.0,"Credit Suisse Maintains Outperform on Illumina, Inc., Lowers PT to $59.00",2013-01-29 07:41:00-05:00,ILMN,positive
660444.0,UPDATE: Illumina Posts Higher Q4 Profit,2013-01-29 03:26:00-05:00,ILMN,positive
660445.0,"Illumina, Inc. Sees FY2013 EPS $1.55-1.62 vs $1.72 Est",2013-01-28 16:08:00-05:00,ILMN,neutral
660446.0,"Illumina, Inc. Reports Q4 EPS of $0.42, Inline; Revenue of $309.0M vs $305.44M Est",2013-01-28 16:07:00-05:00,ILMN,neutral
660447.0,"Earnings Scheduled For January 28, 2013",2013-01-28 01:08:00-05:00,ILMN,neutral
660448.0,"Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)",2013-01-26 12:17:00-05:00,ILMN,positive
660449.0,"The Week Ahead: Earnings from Facebook, Ford, Caterpillar; US Jobs Report",2013-01-25 18:15:00-05:00,ILMN,neutral
660450.0,"Illumina Reports Q4 Prelim. Sales $309M vs $302M Est, Sees EPS Tracking to Mid-Point of Range",2013-01-09 13:13:00-05:00,ILMN,neutral
660451.0,"Benzinga's M&A Chatter for Tuesday January 8, 2013",2013-01-08 20:07:00-05:00,ILMN,neutral
660452.0,"ISI Group Maintains Neutral on Illumina, Inc., Lowers PT to $53.50",2013-01-08 16:08:00-05:00,ILMN,negative
660453.0,"Illumina Says Purchased Moleculo, Sees Deal Accretive to 2013 Results",2013-01-08 11:54:00-05:00,ILMN,neutral
660454.0,Life Technologies Spikes Lower as Illumina Launches CE Competitor,2013-01-08 11:49:00-05:00,ILMN,negative
660455.0,Illumina Withdraws Offer to Buy Complete Genomics,2013-01-08 11:39:00-05:00,ILMN,neutral
660456.0,"Illumina CEO Presenting at JPMorgan Conference: Sees Sales Growth ~15%, Sees EPS Tracking to Mid Point of Range",2013-01-08 11:35:00-05:00,ILMN,positive
660457.0,"Benzinga's M&A Chatter for Monday January 7, 2013",2013-01-07 17:16:00-05:00,ILMN,neutral
660458.0,Major Averages Record Small Losses to Start Week,2013-01-07 16:45:00-05:00,ILMN,negative
660459.0,"Mid-Afternoon Market Update: Markets Down Slightly, Molycorp Rises",2013-01-07 16:00:00-05:00,ILMN,neutral
660460.0,Illumina Falls After Announcing Acquisition of Verinata Health,2013-01-07 15:58:00-05:00,ILMN,neutral
660461.0,"Mid-Day Market Update: SolarCity Wins Big, SunPower Continues its Fall",2013-01-07 13:10:00-05:00,ILMN,positive
660462.0,UPDATE: Citigroup Reiterates Illumina at Neutral on Valuation   ,2013-01-07 13:09:00-05:00,ILMN,neutral
660463.0,"Vista Capital Sends Letter to Illumina Chairman, Says Owns 300K+ Shares, Should Disclose Informal Offers from Roche - Bloomberg",2013-01-07 10:50:00-05:00,ILMN,positive
660464.0,"Mid-Morning Market Update: Markets Giving Back Some Gains, Big Banks Catch a Break",2013-01-07 10:36:00-05:00,ILMN,positive
660465.0,Benzinga's Top Pre-Market Losers,2013-01-07 08:19:00-05:00,ILMN,negative
660466.0,Illumina Falls 10% Pre-Market on Comments by Roche Chairman they are No Longer Pursuing Acquisition,2013-01-07 07:20:00-05:00,ILMN,negative
660467.0,A Peek Into The Market Before The Trading Starts,2013-01-07 07:18:00-05:00,ILMN,neutral
660468.0,Illumina  to Acquire Verinata Health for $350M,2013-01-07 06:08:00-05:00,ILMN,neutral
660469.0,Roche Chairman Says No Longer Considering Bid for Illumina -Reuters,2013-01-06 14:25:00-05:00,ILMN,negative
660470.0,UPDATE: Wedbush Downgrades Illumina to Neutral on Risk/Reward  ,2013-01-04 09:59:00-05:00,ILMN,neutral
660471.0,"Wedbush Downgrades Illumina, Inc. to Neutral, Maintains $52.00 PT",2013-01-04 08:35:00-05:00,ILMN,neutral
660472.0,UPDATE: Piper Jaffray Upgrades Illumina to Overweight on Positive Sequencing Update  ,2013-01-04 08:29:00-05:00,ILMN,positive
660473.0,Benzinga's Top Upgrades,2013-01-04 07:18:00-05:00,ILMN,positive
660474.0,"Piper Jaffray Upgrades Illumina, Inc. to Overweight, Raises PT to $61.00",2013-01-04 07:02:00-05:00,ILMN,negative
660475.0,"Short Interest Swings in Biotech Stocks (CELG, GILD, REGN)",2012-12-28 11:10:00-05:00,ILMN,positive
660476.0,"Mid-Day Market Update: Steelcase Boosts, Greenbrier Drops",2012-12-20 13:50:00-05:00,ILMN,positive
660477.0,"Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)",2012-12-12 12:57:00-05:00,ILMN,positive
660478.0,"Option Alert: Illumina January 60 Call; Block Trade: 1,750 Contracts @$1.05; Currently $52.32",2012-12-10 12:51:00-05:00,ILMN,negative
660479.0,"BioMarin, Prestige Brands and Other Top Performing Health Care Stocks in November",2012-12-02 20:29:00-05:00,ILMN,positive
660480.0,"RIM, Green Mountain and Other Top Performing Nasdaq Stocks in November",2012-12-01 13:38:00-05:00,ILMN,positive
660481.0,"Illumina Shares Touch $52, Now Up Just 1.5%; Stock Hit as High as $53.91 Earlier",2012-11-29 11:03:00-05:00,ILMN,positive
660482.0,"Illumina Shares Jumping, Now Up 5%",2012-11-29 10:30:00-05:00,ILMN,positive
660483.0,"Baird Downgrades Illumina from Outperform to Neutral, Maintains PT at $54",2012-11-26 10:18:00-05:00,ILMN,neutral
660484.0,Illumina Granted Review in Patent Litigation Against Complete Genomics,2012-11-26 06:34:00-05:00,ILMN,positive
660485.0,"Benzinga's M&A Chatter for Friday November 23, 2012",2012-11-24 10:16:00-05:00,ILMN,neutral
660486.0,Illumina Rises 4% Pre-Market on Unconfirmed Chatter,2012-11-23 08:45:00-05:00,ILMN,negative
660487.0,"Benzinga's M&A Chatter for Wednesday November 21, 2012",2012-11-22 12:06:00-05:00,ILMN,neutral
660488.0,Illumina Spikes Higher,2012-11-21 15:46:00-05:00,ILMN,neutral
660489.0,"Illumina Sends Letter to Complete Genomics Board, Expecting No Antitrust Issues with Bid",2012-11-21 08:59:00-05:00,ILMN,negative
660490.0,Benzinga's Top Pre-Market Losers,2012-11-19 08:15:00-05:00,ILMN,negative
660491.0,Illumina Confirms It is 'Party H' in Complete Genomics Filing,2012-11-16 16:21:00-05:00,ILMN,positive
660492.0,"Short Interest Swings in Biotech Stocks (AMGN, BIIB, VRTX)",2012-11-12 13:24:00-05:00,ILMN,positive
660493.0, Illumina Announce VWR International to Distribute qPCR Portfolio ,2012-11-12 06:37:00-05:00,ILMN,neutral
660494.0,Roche Spokesperson Declines Comment on Earlier Illumina Takeover Chatter,2012-11-07 18:01:00-05:00,ILMN,neutral
660495.0,"Benzinga's M&A Chatter for Wednesday November 7, 2012",2012-11-07 17:54:00-05:00,ILMN,neutral
660496.0,Illumina Spokesperson Says Not Aware of News to Account for Earlier Spike,2012-11-07 14:00:00-05:00,ILMN,neutral
660497.0,Illumina Shares Now Up Just 1.7% to $48.51 After Spiking to Intraday High of $52.22,2012-11-07 13:27:00-05:00,ILMN,positive
660498.0,Illumina Strength Could Also be Related to Presentation ASHG COnference in San Francisco,2012-11-07 13:22:00-05:00,ILMN,positive
660499.0,Hearing Renewed Chatter of Roche Offer for Illumina,2012-11-07 13:13:00-05:00,ILMN,neutral
660500.0,FROM EARLIER: Caris Life Sciences Selects Illumina's MiSeq System to Enable Next-Generation Sequencing as Part of its Molecular Profiling Service  ,2012-11-07 13:11:00-05:00,ILMN,neutral
660501.0,Illumina Shares Spike 3+% Over Last Few Minutes,2012-11-07 13:11:00-05:00,ILMN,positive
660502.0,Illumina Spikes Higher,2012-11-07 13:07:00-05:00,ILMN,neutral
660503.0,"Short Interest Swings in Biotech Stocks (BIIB, GILD, VVUS)",2012-10-25 14:09:00-04:00,ILMN,positive
660504.0,"Goldman Sachs Maintains Illumina at Neutral, Lowers PT from $50 to $48",2012-10-24 15:16:00-04:00,ILMN,negative
660505.0,CLSA Downgraded Illumina from Outperform to Underperform,2012-10-24 10:34:00-04:00,ILMN,neutral
660506.0,"Illumina Guides FY Revenue $1.134-1.144B, Had Seen $1.1-1.175B; Guides FY EPS $1.54-1.59, Had Seen $1.50-1.60 vs $1.56 Est",2012-10-23 16:44:00-04:00,ILMN,neutral
660507.0,Illumina Reports Q3 EPS $0.41 vs $0.39 Est; Revenues $285.9M vs $284.76M Est,2012-10-23 16:43:00-04:00,ILMN,neutral
660508.0,Complete Genomics Reports Favorable Ruling in Patent Suit Against Illumina,2012-10-18 06:59:00-04:00,ILMN,positive
660509.0,"Citigroup Maintains Illumina at Neutral, Raises PT from $44 to $53",2012-10-16 11:00:00-04:00,ILMN,neutral
660510.0,From Earlier: Illumina Launches Infinium HumanCore Arrays for Economical Large-Scale Genetic Studies,2012-10-16 09:42:00-04:00,ILMN,neutral
660511.0,Benzinga Mid-Afternoon Market Update ,2012-10-15 15:54:00-04:00,ILMN,neutral
660512.0,"Short Interest Swings in Biotech Stocks (BIIB, CELG, GILD)",2012-10-15 06:59:00-04:00,ILMN,positive
660513.0,"Cantor Fitzgerald Maintains Illumina at Hold, Raises PT from $43 to $45",2012-10-10 08:49:00-04:00,ILMN,neutral
660514.0,Illumina Confirms CEO Not Able to Attend Consumer Genetics Conference in Boston Due to Scheduling Conflict,2012-10-03 12:13:00-04:00,ILMN,negative
660515.0,Hearing Unconfirmed Chatter Illumina Cancelled Out of Conference,2012-10-03 11:12:00-04:00,ILMN,negative
660516.0,"Benzinga's M&A Chatter for Tuesday October 2, 2012",2012-10-02 20:23:00-04:00,ILMN,neutral
660517.0,UPDATE: Illumina Trading Up Nearly 7% After Reports The Company Could be Acquired for $60 per Roche,2012-10-02 09:30:00-04:00,ILMN,neutral
660518.0,Roche Declined to Comment on Rumors of Illumina Takeover -Bloomberg,2012-10-02 09:03:00-04:00,ILMN,neutral
660519.0,Benzinga's Top Pre-Market Gainers,2012-10-02 08:10:00-04:00,ILMN,positive
660520.0,Knome Taking Orders for knoSYS™100,2012-09-27 07:22:00-04:00,ILMN,neutral
660521.0,"Short Interest in Biotech Firms Resumes (BIIB, GILD, ILMN, REGN)",2012-09-26 13:22:00-04:00,ILMN,positive
660522.0,"Benzinga's M&A Chatter for Tuesday September 18, 2012:",2012-09-18 17:01:00-04:00,ILMN,neutral
660523.0,Illumina Spikes Higher,2012-09-18 10:25:00-04:00,ILMN,neutral
660524.0,"Illumnina CEO Says Board Stopped Talks About Acceptable Price, Roche's Public $6.7B Bid Limited Talks -Bloomberg",2012-09-18 10:13:00-04:00,ILMN,negative
660525.0,Illumina Gets Order Worth $17M Over Next Five Years,2012-09-18 08:43:00-04:00,ILMN,positive
660526.0,Illumina Announces  TruSeq Stranded mRNA and Total RNA Sequencing Sample Preparation Solutions ,2012-09-18 06:44:00-04:00,ILMN,positive
660527.0,Illumina Spikes Higher,2012-09-14 12:40:00-04:00,ILMN,neutral
660528.0,Short Sellers Shy Away from Biotech Firms,2012-09-13 13:34:00-04:00,ILMN,negative
660529.0,Illumina Plans to Submit Miseq for FDA Clearance Before End of Year,2012-09-11 06:31:00-04:00,ILMN,neutral
660530.0,Illumina Names Paul Bianchi as Senior Vice President of Human Resources ,2012-09-10 06:39:00-04:00,ILMN,neutral
660531.0,Illumina Announces Favorable Outcome of its Patent Litigation Against Helicos BioSciences Corporation  ,2012-08-29 16:11:00-04:00,ILMN,positive
660532.0,NanoString Technologies Names Dale R. Levitzke Vice President of Global Sales for Life Sciences   ,2012-08-07 07:31:00-04:00,ILMN,neutral
660533.0,"Benzinga's M&A Chatter for Wednesday July 25, 2012",2012-07-25 17:09:00-04:00,ILMN,neutral
660534.0,Complete Genomics Spiking Higher on Takeover Chatter,2012-07-25 09:51:00-04:00,ILMN,neutral
660535.0,Illumina Reports Q2 EPS $0.40 vs $0.36 Est; Revenues $280.6M vs $278.71M Est,2012-07-24 16:33:00-04:00,ILMN,neutral
660536.0,"Barclays Maintains Illumina at Overweight, Lowers PT from $60 to $55",2012-07-23 12:35:00-04:00,ILMN,negative
660537.0,A Peek Into The Market Before The Trading Starts,2012-07-23 07:20:00-04:00,ILMN,neutral
660538.0,Illumina Countersues IBS and Qiagen for Patent Infringement   ,2012-07-23 06:36:00-04:00,ILMN,negative
660539.0,"UPDATE: ISI Group Initiates Market Weight, $45 PT on Illumina on Soft Demand Environment  ",2012-07-10 09:30:00-04:00,ILMN,negative
660540.0,"ISI Group Initiates Coverage on Illumina at Market Weight, Announces PT of $45",2012-07-10 06:07:00-04:00,ILMN,neutral
660541.0,Top 4 Mid-Cap Stocks In The Biotechnology Industry With The Highest Cash,2012-07-02 02:10:00-04:00,ILMN,positive
660542.0,A Peek Into The Market Before The Trading Starts,2012-06-20 07:20:00-04:00,ILMN,neutral
660543.0,Illumina Announces RapidTrack Whole Genome Sequencing Service   ,2012-06-20 06:36:00-04:00,ILMN,neutral
660544.0,"Illumina Files Second Patent Infringement Suit Against Complete Genomics, Inc.   ",2012-06-18 06:32:00-04:00,ILMN,negative
660545.0,Illumina Spiking Higher,2012-06-14 09:55:00-04:00,ILMN,neutral
660546.0,Illumina Says Funding Environment is Improving,2012-06-13 10:11:00-04:00,ILMN,positive
660547.0,Illumina Says Compound Annual Growth Rate is 83%,2012-06-13 09:44:00-04:00,ILMN,positive
660548.0,Illumina Presenting at William Blair Growth Stock Conference,2012-06-13 09:42:00-04:00,ILMN,positive
660549.0,Five Stocks Hedge Funds Are Buying Like Crazy,2012-06-01 19:55:00-04:00,ILMN,neutral
660550.0,Illumina Trading 1.2% Higher on Heavy Volume; Currently at $44,2012-05-25 11:07:00-04:00,ILMN,neutral
660551.0,Illumina Spiking Higher,2012-05-25 10:57:00-04:00,ILMN,neutral
660552.0,GlaxoSmithKline to Get Hostile with Offer for Human Genome,2012-05-09 09:15:00-04:00,ILMN,negative
660553.0,"From Earlier, Roche Pursuing Other Opportunities After Failed Illumina Bid - CEO",2012-05-03 10:56:00-04:00,ILMN,negative
660554.0,"UBS Maintains Illumina at Neutral, Lowers PT from $55 to $48",2012-04-24 10:09:00-04:00,ILMN,negative
660555.0,UPDATE: Wedbush Lowers Illumina's PT,2012-04-24 09:29:00-04:00,ILMN,negative
660556.0,UPDATE: Citigroup Raises PT to $44 on Illumina: Strong but Inconsistent Q1   ,2012-04-24 08:36:00-04:00,ILMN,positive
660557.0,UPDATE: J.P. Morgan Lowers Illumina's PT,2012-04-24 07:49:00-04:00,ILMN,negative
660558.0,"Wedbush Securities Maintains Illumina at Outperform, Lowers PT from $65 to $52",2012-04-24 07:21:00-04:00,ILMN,positive
660559.0,"Citigroup Maintains Illumina at Neutral, Raises PT from $32 to $44",2012-04-24 07:09:00-04:00,ILMN,neutral
660560.0,"JP Morgan Maintains Illumina at Overweight, Lowers PT from $70 to $55",2012-04-24 06:48:00-04:00,ILMN,negative
660561.0,Illumina Launches MyGenome App for iPad,2012-04-24 06:40:00-04:00,ILMN,neutral
660562.0,Illumina Up Slightly on Q1 Beat ,2012-04-23 16:42:00-04:00,ILMN,neutral
660563.0,UPDATE: Ilumina Reaffirms Forecast,2012-04-23 16:10:00-04:00,ILMN,neutral
660564.0,UPDATE: Illumina May Buy Back Up to $250M Shares,2012-04-23 16:06:00-04:00,ILMN,positive
660565.0,Illumina Reports Q1 EPS $0.36 vs $0.32 Est; Revenues $273M vs $264.26M Est,2012-04-23 16:06:00-04:00,ILMN,neutral
660566.0,Wedbush: Illumina's 1Q12 Preview,2012-04-23 09:23:00-04:00,ILMN,neutral
660567.0,"Benzinga'a M&A Chatter for Wednesday April 18, 2012",2012-04-18 18:41:00-04:00,ILMN,neutral
660568.0,"GNOM Analyst: However, Roche Would Like Wait for Things to Settle Down; ILMN Overvalued in Relation to its Technology; PACB is Likely Another Candidate",2012-04-18 13:34:00-04:00,ILMN,positive
660569.0,"GNOM Analyst: GNOM Would Likely Be Next Candidate for Roche after ILMN, Has a Proven Technology and It's Valuable",2012-04-18 13:32:00-04:00,ILMN,positive
660570.0,Complete Genomics Spokesperson Has No Response to Earlier Analyst Comment That Roche Could Now Be a Potential Buyer,2012-04-18 13:02:00-04:00,ILMN,negative
660571.0,Hearing First Analysis Upgrades Illumina,2012-04-18 12:37:00-04:00,ILMN,neutral
660572.0,Hearing Morgan Stanley Saying They Don't Believe Roche is Out as a Bidder for Illumina,2012-04-18 12:32:00-04:00,ILMN,neutral
660573.0,Notable Options Activity in Illumina Inc,2012-04-18 10:10:00-04:00,ILMN,neutral
660574.0,Hearing JP Morgan Defending Illumina,2012-04-18 09:51:00-04:00,ILMN,positive
660575.0,Illumina Wins Shareholder Support for Board Slate,2012-04-18 09:20:00-04:00,ILMN,positive
660576.0,Roche Decides Not to Extend Its Tender Offer for Illumina on Apparent Re-Election of Incumbent Directors; Says Offer Above $51 Not in Shareholder Interest,2012-04-18 09:07:00-04:00,ILMN,negative
660577.0,"Notable Options Activity in Illumina, Inc",2012-04-17 14:36:00-04:00,ILMN,neutral
660578.0,Sequenom Announces Amendment to Multi-Year Supply Agreement with Illumina  ,2012-04-17 07:36:00-04:00,ILMN,positive
660579.0,Illumina Trading 5.3% Lower on Heavy Volume; Currently at $46.88,2012-04-13 12:26:00-04:00,ILMN,negative
660580.0,"Benzinga's M&A Chatter for Thursday April 12, 2012",2012-04-12 18:19:00-04:00,ILMN,neutral
660581.0,Roche Will Not Increase Offer if No Response from Illumina -Bloomberg,2012-04-12 11:19:00-04:00,ILMN,negative
660582.0,Illumina Trading 3.9% Lower on Heavy Volume; Currently at $50.54,2012-04-12 11:17:00-04:00,ILMN,negative
660583.0,Benzinga's Top Pre-Market Losers,2012-04-12 08:12:00-04:00,ILMN,negative
660584.0,From Earlier: Roche Issues Statement Regarding Illumina Offer  ,2012-04-12 07:42:00-04:00,ILMN,neutral
660585.0,UPDATE: Roche Says Negotiations with Illumina May Lead to Higher Offer; $51 Bid More Than Reasonable Starting Point for Talks,2012-04-11 16:19:00-04:00,ILMN,neutral
660586.0,Roche Sends Letter to Illumina Shareholders; Asks Shareholders to Vote for Nominees,2012-04-11 16:03:00-04:00,ILMN,neutral
660587.0,Roche sends open letter to Illumina shareholders,2012-04-11 16:02:00-04:00,ILMN,neutral
660588.0,"ETFs For Momentum Stocks (FBT, PNQI, HDGE)",2012-04-10 13:07:00-04:00,ILMN,neutral
660589.0,Illumina Says Glass Lewis Recommends Voting for Illumina Nominees,2012-04-10 09:01:00-04:00,ILMN,positive
660590.0,Illumina's Board Recommends Stockholders Reject Roche Offer,2012-04-09 09:01:00-04:00,ILMN,negative
660591.0,Roche disappointed with ISS recommendation,2012-04-06 18:38:00-04:00,ILMN,negative
660592.0,From Earlier: Roche Sends Second Letter To Illumina Shareholders  ,2012-04-04 07:08:00-04:00,ILMN,neutral
660593.0,Editor of Little Bear Research Blog Hears Roche Will Raise Bid on Ilumina to $57.50 Per Share,2012-04-03 14:58:00-04:00,ILMN,positive
660594.0,Illumina's Board of Directors Sends Third Letter to Stockholders   ,2012-04-03 09:02:00-04:00,ILMN,neutral
660595.0,A Peek Into The Market Before The Trading Starts,2012-04-03 07:17:00-04:00,ILMN,neutral
660596.0,Roche Disappointed By Illumina's Board Of Directors' Rejection   ,2012-04-03 06:43:00-04:00,ILMN,negative
660597.0,Illumina Trading 2.4% Lower on Heavy Volume; Currently at $51.37,2012-04-02 16:00:00-04:00,ILMN,negative
660598.0,"ProShares Files For Arbitrage, Private Equity ETFs (PSP, MNA)",2012-04-02 14:22:00-04:00,ILMN,neutral
660599.0,UPDATE: Illumina's Board Unanimously Rejects Roche's Revised Unsolicited Offer   ,2012-04-02 13:58:00-04:00,ILMN,negative
660600.0,Illumina's Board Unanimously Rejects Roche's $51 Offer,2012-04-02 13:58:00-04:00,ILMN,negative
660601.0,Market Roundup,2012-04-02 11:36:00-04:00,ILMN,neutral
660602.0,Morgan Stanley Gives Illumina Equal-Weight Rating,2012-04-02 10:33:00-04:00,ILMN,neutral
660603.0,J.P. Morgan Reiterates Overweight Rating for Illumina,2012-04-02 10:05:00-04:00,ILMN,negative
660604.0,From Earlier: Illumina Sees Q1 Revenue of $270M vs $257.42M Est ,2012-04-02 07:49:00-04:00,ILMN,neutral
660605.0,Illumina Issues Q1 Forecast,2012-04-02 05:09:00-04:00,ILMN,neutral
660606.0,Roche,2012-03-29 18:37:00-04:00,ILMN,neutral
660607.0,Roche Ups Bid For Illumina 15% To $51 A Share,2012-03-29 14:10:00-04:00,ILMN,positive
660608.0,Top Narrow Based Indexes For March 29,2012-03-29 11:16:00-04:00,ILMN,positive
660609.0,Morgan Stanley Comments on Higher Bid for Illumina,2012-03-29 09:57:00-04:00,ILMN,neutral
660610.0,Oppenheimer Maintains Perform on Illumina After Increased Roche Bid,2012-03-29 09:51:00-04:00,ILMN,positive
660611.0,Illumina Rises 4% Pre-Market on New Roche Offer of $51/Share,2012-03-29 09:03:00-04:00,ILMN,neutral
660612.0,JP Morgan Comments on Raised Bid from Roche for Illumina,2012-03-29 08:20:00-04:00,ILMN,positive
660613.0,From Earlier: Illumina Advises Stockholders to Defer Taking Any Action in Response to Roche's Increased Offer  ,2012-03-29 07:50:00-04:00,ILMN,neutral
660614.0,Benzinga's Top Pre-Market Gainers,2012-03-29 07:38:00-04:00,ILMN,positive
660615.0,"Financial Breakfast: Morning News Summary for March 29, 2012",2012-03-29 07:26:00-04:00,ILMN,neutral
660616.0,Hearing JP Morgan Positive on Illumina on Raised Roche Offer,2012-03-29 07:15:00-04:00,ILMN,positive
660617.0,Roche Increases Offer Price For Illumina Shares To US$ 51.00 Per Share   ,2012-03-29 07:03:00-04:00,ILMN,positive
660618.0,Columbia University Sues Illumina Over DNA-Related Patents -Reuters,2012-03-26 11:58:00-04:00,ILMN,neutral
660619.0,Illumina Writes to Stockholders with Plea to Reject Roche,2012-03-26 10:43:00-04:00,ILMN,negative
660620.0,Illumina's Board of Directors Sends Second Letter to Stockholders; Urges Stockholders To Reject Roche's Hostile Effort ,2012-03-26 09:02:00-04:00,ILMN,negative
660621.0,From Earlier: Illumina Comments on Second Extension of Roche's Unsolicited Tender Offer  ,2012-03-26 07:22:00-04:00,ILMN,neutral
660622.0,Morgan Stanley Initiates Coverage on Illumina at Equal-weight,2012-03-22 11:50:00-04:00,ILMN,neutral
660623.0,A Peek Into The Market Before The Trading Starts,2012-03-22 07:20:00-04:00,ILMN,neutral
660624.0,"Macrogen, Inc. Increases Investment in Illumina's Next-Generation Sequencing Technology   ",2012-03-22 06:36:00-04:00,ILMN,neutral
660625.0,Illumina Spiking Higher on Heavy Volume; Currently at $50.07,2012-03-20 11:05:00-04:00,ILMN,neutral
660626.0,Roche Files Definitive Proxy Statement; Urges Illumina Shareholders to Tender Shares,2012-03-20 09:31:00-04:00,ILMN,positive
660627.0,Illumina Spiking Lower,2012-03-19 15:19:00-04:00,ILMN,negative
660628.0,Illumina Spiking Higher,2012-03-19 10:13:00-04:00,ILMN,neutral
660629.0,Illumina Files Definitive Proxy Materials and Sends Letter to Stockholders   ,2012-03-19 06:41:00-04:00,ILMN,neutral
660630.0,Hearing dealReporter Saying Roche Won't Raise Offer for Illumina,2012-03-15 12:27:00-04:00,ILMN,neutral
660631.0,Negative Rumors Circulate About Illumina,2012-03-15 12:27:00-04:00,ILMN,negative
660632.0,Roche Says 2nd Request for Information on Illumina Deal Relates to Info for Microarray Business,2012-03-13 17:42:00-04:00,ILMN,neutral
660633.0,Roche Receives Request for Illumina Deal,2012-03-13 17:38:00-04:00,ILMN,neutral
660634.0,Notable Put Options Activity in Illumina,2012-03-13 13:50:00-04:00,ILMN,neutral
660635.0,Cancer Scans May Give False Picture of Tumor Genes -NEJM,2012-03-07 17:01:00-05:00,ILMN,negative
660636.0,"Illumina CEO on CNBC Says Roche Offer Dramatically Undervalues Company, Board Will Look at Any Offer, but Not Currently in Negotiation",2012-03-06 16:54:00-05:00,ILMN,neutral
660637.0,Morgan Stanley Initiates Coverage on Illumina at Equal-weight,2012-03-06 09:28:00-05:00,ILMN,neutral
660638.0,Notable Call Options Activity in Illumina,2012-03-05 10:23:00-05:00,ILMN,neutral
660639.0,"Option Alert: Illumina March 55 Call; Block Trade, 8,043 Contracts",2012-03-05 09:51:00-05:00,ILMN,negative
660640.0,Complete Genomics Spiking Higher on Positive Report,2012-03-02 11:10:00-05:00,ILMN,positive
660641.0,Hearing Report Out Saying GNOM's Product is More Effective than ILMN's,2012-03-02 11:10:00-05:00,ILMN,positive
660642.0,UPDATE: Illumina Announces Outcome of First Phase of Its Patent Litigation Against LadaTech   ,2012-03-01 16:16:00-05:00,ILMN,negative
660643.0,LadaTech announces Illumina Found to Infringe Patent,2012-03-01 11:51:00-05:00,ILMN,neutral
660644.0,Illumina Trading 0.7% Lower on Heavy Volume; Currently at $50.9,2012-03-01 11:51:00-05:00,ILMN,negative
660645.0,LadaTech: Del Jury Finds That Illumina Infringed Patent On Solexa DNA Sequencing Technology,2012-03-01 11:51:00-05:00,ILMN,neutral
660646.0,From Earlier: Illumina Comments on Roche's Unsolicited Tender Offer Extension  ,2012-02-27 07:20:00-05:00,ILMN,neutral
660647.0,From Earlier: Roche Extends Tender Offer for Illumina,2012-02-27 07:18:00-05:00,ILMN,positive
660648.0,Illumina Spiking Lower,2012-02-22 12:03:00-05:00,ILMN,negative
660649.0,"Wedbush Reiterates Outperform, $65 Target on Illumina",2012-02-21 08:31:00-05:00,ILMN,neutral
660650.0,A Peek Into The Market Before The Trading Starts,2012-02-16 07:26:00-05:00,ILMN,neutral
660651.0,Illumina Announces Favorable Patent Claim Construction Ruling in Litigation Against Complete Genomics,2012-02-16 06:32:00-05:00,ILMN,positive
660652.0,Illumina Spiking Higher on Heavy Volume; Currently at $54.63,2012-02-14 14:47:00-05:00,ILMN,neutral
660653.0,Illumina Spiking Higher,2012-02-10 11:56:00-05:00,ILMN,neutral
660654.0,Illumina Spokesperson Has No Comment on Earlier Report of Icahn Saying Company Worth $75/Share,2012-02-09 12:33:00-05:00,ILMN,negative
660655.0,Illumina Analyst: Hard to See Any Other Bidders; Fit with Roche is Best.  Potential Buyers Need A Diagnostic Business to Realize Full Synergies.,2012-02-09 11:46:00-05:00,ILMN,positive
660656.0,Hearing Ichan Thinks Illumina Worth $75 to $80/Share,2012-02-09 09:52:00-05:00,ILMN,positive
660657.0,Illumina Reports Q4 EPS $0.35 vs $0.30 Est; Revenues $250.1M vs $248.31M Est	 			,2012-02-08 16:23:00-05:00,ILMN,neutral
660658.0,From Earlier: Roche Disappointed by the Actions of Illumina's Board of Directors  ,2012-02-08 08:19:00-05:00,ILMN,negative
660659.0,"Financial Breakfast: Morning News Summary for February 08, 2012",2012-02-08 07:27:00-05:00,ILMN,neutral
660660.0,UPDATE: Deutsche Bank Raises Target to $51 on Illumina,2012-02-08 07:13:00-05:00,ILMN,neutral
660661.0,Roche Takeover of Illumnia Begins to Fail,2012-02-08 06:51:00-05:00,ILMN,negative
660662.0,Illumina's Board Unanimously Rejects Roche's Unsolicited Tender Offer as Inadequate  ,2012-02-07 16:05:00-05:00,ILMN,negative
660663.0,Illumina Comments on Roche's Director Nominees and Proposals   ,2012-01-31 15:55:00-05:00,ILMN,neutral
660664.0,Earnings Scheduled For January 31,2012-01-31 03:17:00-05:00,ILMN,neutral
660665.0,"Benzinga's M&A Chatter for Friday January 27, 2012",2012-01-27 17:40:00-05:00,ILMN,neutral
660666.0,Will Illumina Be Bought Out?,2012-01-27 11:02:00-05:00,ILMN,neutral
660667.0,UPDATE: Illumina Confirms Roche Begins Tender Offer,2012-01-27 10:14:00-05:00,ILMN,neutral
660668.0,"Illumina's Board to Review Offer from Roche; Reaffirms Qr, FY2011 Forecast",2012-01-27 10:13:00-05:00,ILMN,neutral
660669.0,"Benzinga's M&A Chatter for Thursday January 26, 2012",2012-01-26 18:24:00-05:00,ILMN,neutral
660670.0,"Roche Responds to Illumina Board, Says Confident Holders Will See Value in Offer",2012-01-26 18:01:00-05:00,ILMN,positive
660671.0,"Small Biotechnology Stocks Roar, Profit Now",2012-01-26 14:03:00-05:00,ILMN,positive
660672.0,Illumina Adopts Stockholder Rights Agreement   ,2012-01-26 06:31:00-05:00,ILMN,positive
660673.0,"Benzinga's M&A Chatter for Wednesday January 25, 2012",2012-01-25 20:04:00-05:00,ILMN,neutral
660674.0,Benzinga's Volume Gainers,2012-01-25 15:35:00-05:00,ILMN,neutral
660675.0,Afternoon Movers; Markets Moved Higher,2012-01-25 14:59:00-05:00,ILMN,neutral
660676.0,Hearing William Blair Saying Most Optimistic Takeout Price is $80/Share,2012-01-25 14:05:00-05:00,ILMN,positive
660677.0,Wedbush Raises Target to $50 on Illumina,2012-01-25 13:15:00-05:00,ILMN,neutral
660678.0,Hearing Barclays Saying Illumina Takeout Price in $60 to $65 Range,2012-01-25 12:41:00-05:00,ILMN,neutral
660679.0,Will Roche's Takeover Bid Help People Predict Diseases?,2012-01-25 12:39:00-05:00,ILMN,positive
660680.0,Illumina Trading 44.3% Higher on Heavy Volume; Currently at $54.39,2012-01-25 10:43:00-05:00,ILMN,neutral
660681.0,"Option Alert: Illumina March 60 Call; Block Trade, 2,180 Contracts",2012-01-25 09:59:00-05:00,ILMN,negative
660682.0,JP Morgan Raises Target to $70 on Illumina,2012-01-25 08:55:00-05:00,ILMN,positive
660683.0,Auriga Maintains Buy on Illumina After Roche Acquisition Proposal,2012-01-25 08:25:00-05:00,ILMN,neutral
660684.0,Pacific Biosciences of California Surging after Roche's Hostile Takeover of Illumina,2012-01-25 08:19:00-05:00,ILMN,negative
660685.0,Benzinga's Top Pre-Market Gainers,2012-01-25 08:14:00-05:00,ILMN,positive
660686.0,Illumina Surges after Roche's Hostile Takeover,2012-01-25 08:04:00-05:00,ILMN,negative
660687.0,"Pacific Biosciences of California, Complete Genomics Seeing Strength after Roche's Hostile Takeover of Illumina",2012-01-25 07:50:00-05:00,ILMN,positive
660688.0,Goldman Sachs Moves Illumina to Not Rated,2012-01-25 07:37:00-05:00,ILMN,neutral
660689.0,UPDATE: Roche Says Illumina Offer Represents Fair and Full Value; ,2012-01-25 07:26:00-05:00,ILMN,positive
660690.0,Wedbush Securities Raises PT on Illumina to $50,2012-01-25 07:25:00-05:00,ILMN,positive
660691.0,"Roche Offers to Buy Illumina for $44.50/Shr, or $5.7b -Bloomberg",2012-01-25 07:25:00-05:00,ILMN,neutral
660692.0,Piper Jaffray Maintains Neutral on Illumina After Roche's Tender Offer,2012-01-25 07:13:00-05:00,ILMN,neutral
660693.0,Illumina Rises 32% Pre-Market on Roche Offer,2012-01-25 07:02:00-05:00,ILMN,neutral
660694.0,From Earlier: Illumina Board of Directors Says Will Review Unsolicited Acquisition Proposal from Roche  ,2012-01-25 06:56:00-05:00,ILMN,neutral
660695.0,UPDATE: Roche Offers to Acquire All Outstanding Shares of Illumina for $44.50 per Share,2012-01-25 06:53:00-05:00,ILMN,positive
660696.0,Oppenheimer Maintains Perform on Illumina's Proposed Acquisition by Roche,2012-01-25 06:24:00-05:00,ILMN,neutral
660697.0,JP Morgan Raises PT on Illumina to $70,2012-01-25 06:11:00-05:00,ILMN,positive
660698.0,Roche Offering $5.7B for Illumina; $44.50/Share Cash,2012-01-24 22:38:00-05:00,ILMN,neutral
660699.0,"Illumina Spokespeson Comments Company Presented at JP Morgan Healthcare Conference, Announced $250M Revenues and ~$0.34 EPS in Q4.",2012-01-10 12:40:00-05:00,ILMN,positive
660700.0,Illumina Introduces the HiSeq 2500   ,2012-01-10 12:30:00-05:00,ILMN,neutral
660701.0,Ilumina Resumes Trading,2012-01-10 12:24:00-05:00,ILMN,neutral
660702.0,Illumina Says New Machine can Sequence Genome in One Day; Sees Strong Investment in Next Gen Sequencing at JPM Conference,2012-01-10 12:24:00-05:00,ILMN,positive
660703.0,"Illumina Halted, Circuit Breaker, Hearing Chatter Company is Issuing Guidance",2012-01-10 12:20:00-05:00,ILMN,neutral
660704.0,"Trading Halted in Illumina, Code T5",2012-01-10 12:19:00-05:00,ILMN,neutral
660705.0,"Benzinga's M&A Chatter for Wednesday January 4, 2012",2012-01-04 17:19:00-05:00,ILMN,neutral
660706.0,"Illumina Spokesperson, Regarding Earlier Takeover Chatter, Says Company Does Not Respond to Rumors or Speculation",2012-01-04 14:12:00-05:00,ILMN,neutral
660707.0,"Illumina Spokesperson, Regarding Earlier Takeover Chatter, Says Company Does Not Respond to Rumors or Speculation",2012-01-04 14:03:00-05:00,ILMN,neutral
660708.0,Illumina Appoints Marc Stapley as Senior Vice President and Chief Financial Officer   ,2012-01-04 11:51:00-05:00,ILMN,neutral
660709.0,Notable Call Options Activity in Illumina,2012-01-04 10:28:00-05:00,ILMN,neutral
660710.0,"Illumina Spiking Higher on Heavy Volume, May be Attributed to Takeover Chatter; Siemens Rumored Buyer at $44.50/Share",2012-01-04 09:48:00-05:00,ILMN,neutral
660711.0,"UPDATE: Credit Suisse Initiates Neutral, $30 Target on Illumina ",2011-12-15 08:44:00-05:00,ILMN,positive
660712.0,Illumina Spiking Higher on Heavy Volume,2011-12-14 13:42:00-05:00,ILMN,neutral
660713.0,Notable Put Options Activity in Illumina,2011-12-06 13:16:00-05:00,ILMN,neutral
660714.0,Illumina Spokesperson Says Company Does Not Comment on Rumors or Speculation; Regarding Earlier Takeover Chatter,2011-12-05 12:24:00-05:00,ILMN,neutral
660715.0,"Option Alert: Illumina December 34 Call Rises 1,100% on Takeover Chatter",2011-12-05 11:45:00-05:00,ILMN,positive
660716.0,Illumina Spiking Higher; May be Attributed to Takeover Chatter,2011-12-05 11:17:00-05:00,ILMN,neutral
660717.0,Macquarie Downgrades Illumina to Underperform,2011-11-28 07:31:00-05:00,ILMN,neutral
660718.0,"End-of-Day Market Summary for November 2, 2011",2011-11-02 16:18:00-04:00,ILMN,neutral
660719.0,New Siemens - Illumina Partnership Targets Clinical Infectious Disease Testing Using Next-Generation Sequencing  ,2011-11-02 12:09:00-04:00,ILMN,neutral
660720.0,Illumina Moving Higher; Attributed to Abbott Takeover Interest,2011-10-28 09:48:00-04:00,ILMN,positive
660721.0,Piper Jaffray Remains Neutral on Illumina After 8-K Filing,2011-10-26 10:28:00-04:00,ILMN,neutral
660722.0,Goldman Sachs Raises PT on Illumina to $32,2011-10-26 08:27:00-04:00,ILMN,neutral
660723.0,"Bank of America Raises PO on Illumina to $32, Maintains Neutral ",2011-10-26 06:09:00-04:00,ILMN,negative
660724.0,Illumina Spiking Higher on Heavy Volume,2011-10-25 10:28:00-04:00,ILMN,neutral
660725.0,Deutsche Bank Maintains Hold Rating and $30 PT on Illumina,2011-10-25 08:43:00-04:00,ILMN,neutral
660726.0,Illumina Reports Q3 EPS $0.22 vs $0.23 Est; Revenues $235.5M vs $235.33M Est			,2011-10-25 07:15:00-04:00,ILMN,neutral
660727.0,Illumina Spiking Higher on Heavy Volume,2011-10-24 10:43:00-04:00,ILMN,neutral
660728.0,Illumina Announces Novel Human Exome Content Available on Multiple BeadChip Formats  ,2011-10-12 06:55:00-04:00,ILMN,positive
660729.0,Illumina Spiking Higher on Heavy Volume,2011-10-10 10:26:00-04:00,ILMN,neutral
660730.0,UPDATE: Goldman Sachs Lowers Price Target on Illumina to $28,2011-10-10 09:08:00-04:00,ILMN,negative
660731.0,"Deutsche Bank Downgrades Illumina to Hold, PT Lowered to $30",2011-10-10 06:00:00-04:00,ILMN,negative
660732.0,"deCODE Genetics, in Collaboration with Illumina, Discovers Two Rare Variants that Affect the Risk of Gout",2011-10-09 17:51:00-04:00,ILMN,negative
660733.0,"End-of-Day Market Summary for October 7, 2011",2011-10-07 16:15:00-04:00,ILMN,neutral
660734.0,Resistance  10-07-2011,2011-10-07 15:19:00-04:00,ILMN,neutral
660735.0,Midday Losers; Illumina Down 33%,2011-10-07 13:03:00-04:00,ILMN,negative
660736.0,Notable Put Options Activity in Illumina,2011-10-07 11:51:00-04:00,ILMN,neutral
660737.0,"UBS Downgrades Illumina to Neutral, PT Lowered to $32",2011-10-07 10:18:00-04:00,ILMN,negative
660738.0,Wedbush Lowers PT to $35 on Illumina,2011-10-07 09:48:00-04:00,ILMN,negative
660739.0,UPDATE: Citi Lowers PT to $32 on Illumina,2011-10-07 09:27:00-04:00,ILMN,negative
660740.0,Hearing Illumina Downgraded to Hold at Maxim,2011-10-07 09:10:00-04:00,ILMN,neutral
660741.0,UPDATE: Auriga Lowers PT on Illumina to $47,2011-10-07 08:58:00-04:00,ILMN,negative
660742.0,Goldman Sachs Publishes Equity Research Report on Illumina Inc.,2011-10-07 08:49:00-04:00,ILMN,neutral
660743.0,Wedbush Lowers PT on Illumina to $35,2011-10-07 08:13:00-04:00,ILMN,negative
660744.0,UPDATE: Deutsche Bank Downgrades Illumina to Hold,2011-10-07 08:10:00-04:00,ILMN,neutral
660745.0,Oppenheimer Maintains Perform on Illumina,2011-10-07 08:05:00-04:00,ILMN,neutral
660746.0,Oppenheimer Previews 2012 International Congress of Human Genetics,2011-10-07 08:04:00-04:00,ILMN,neutral
660747.0,Deutsche Bank Downgrading Illumina ,2011-10-07 08:03:00-04:00,ILMN,neutral
660748.0,Piper Jaffray Downgrades Illumina,2011-10-07 07:51:00-04:00,ILMN,neutral
660749.0,Illumina Falls 29% Pre-Market After Lowered Guidance Last Night and Analyst Downgrades,2011-10-07 07:46:00-04:00,ILMN,negative
660750.0,Citi Lowers PT on Illumina Inc. to $32,2011-10-07 07:34:00-04:00,ILMN,negative
660751.0,UPDATE: J.P. Morgan Lowers PT on Illumina to $44,2011-10-07 07:33:00-04:00,ILMN,negative
660752.0,Hearing Illumina Downgraded to Neutral at Macquarie,2011-10-07 06:50:00-04:00,ILMN,neutral
660753.0,Hearing Illumina Downgraded to Neutral at Cowen,2011-10-07 06:47:00-04:00,ILMN,neutral
660754.0,Citigroup Lowers PT on Illumina to $32,2011-10-07 06:30:00-04:00,ILMN,negative
660755.0,JP Morgan Lowers PT on Illumina to $44,2011-10-07 06:13:00-04:00,ILMN,positive
660756.0,"Piper Jaffray Downgrades Illumina to Neutral, PT Lowered to $35",2011-10-07 06:05:00-04:00,ILMN,negative
660757.0,"Deutsche Bank Downgrades ILMN, ITC to Hold",2011-10-07 06:01:00-04:00,ILMN,neutral
660758.0,Illumina Announces Preliminary Revenue of $235M for Third Quarter 2011,2011-10-06 17:01:00-04:00,ILMN,neutral
660759.0,"Citigroup Downgrades BDX, ILMN, LIFE to Hold",2011-10-06 05:52:00-04:00,ILMN,neutral
660760.0,Illumina (ILMN): DNA for your portfolio,2011-09-22 20:00:00-04:00,ILMN,neutral
660761.0,J.P. Morgan Maintains Overweight on Illumina,2011-08-03 08:54:00-04:00,ILMN,negative
660762.0,"Last Nights Headlines, Morning Action August 3",2011-08-03 08:37:00-04:00,ILMN,neutral
660763.0,Illumina Announces New $100 Million Share Repurchase Authorization ,2011-08-03 07:09:00-04:00,ILMN,positive
660764.0,Market Losers as of 10AM,2011-07-27 09:56:00-04:00,ILMN,negative
660765.0,Goldman Sachs Maintains Buy Rating On Illumina,2011-07-27 09:27:00-04:00,ILMN,neutral
660766.0,JP Morgan Recaps 2Q for Illumina Inc,2011-07-27 08:28:00-04:00,ILMN,positive
660767.0,Goldman Sachs Lowers PT on Illumina To $76,2011-07-27 07:17:00-04:00,ILMN,negative
660768.0,Illumina Reports Q2 EPS of $0.38 vs. $0.37 Est; Revenues $287.5M vs. $281.62M Est                ,2011-07-26 16:11:00-04:00,ILMN,neutral
660769.0,Options Brief: Illumina,2011-07-20 10:12:00-04:00,ILMN,neutral
660770.0,Illumina Selected as a Preferred Service Provider for Cancer Research UK   ,2011-07-14 09:21:00-04:00,ILMN,negative
660771.0,Oppenheimer Reiterates Outperform on Sequenom,2011-07-12 08:19:00-04:00,ILMN,neutral
660772.0,Deutsche Bank Updates 7/11/11,2011-07-11 07:49:00-04:00,ILMN,neutral
660773.0,Sequenom Announces Multi-Year Supply Agreement With Illumina,2011-07-11 07:01:00-04:00,ILMN,positive
660774.0,Deutsche Bank Healthcare Services PT Changes 7/11,2011-07-11 06:06:00-04:00,ILMN,neutral
660775.0,Biggest Pre-Market Winners and Losers,2011-07-07 09:24:00-04:00,ILMN,negative
660776.0,Morgan Stanley Discontinuations 7/6 Continued,2011-07-07 07:19:00-04:00,ILMN,neutral
660777.0,Illumina Spiking Higher on Heavy Volume,2011-07-05 13:39:00-04:00,ILMN,neutral
660778.0,Mad Money Lightning Round: Cramer Advises Investors To Buy Illumina,2011-06-30 01:09:00-04:00,ILMN,negative
660779.0,Illumina Brings Down Cost Of DNA Analysis,2011-06-28 14:17:00-04:00,ILMN,neutral
660780.0,Goldman Sachs Updates Illumina Estimates,2011-06-24 07:37:00-04:00,ILMN,neutral
660781.0,Can Genetics Gear Maker Illumina Help  Investors Crack The Code For Profits?,2011-06-21 12:30:00-04:00,ILMN,positive
660782.0,U.S. Stocks Ease From Day's Highs; Illumina Up 2%,2011-06-17 12:07:00-04:00,ILMN,positive
660783.0,Illumina Cuts Price of Whole-Genome Sequencing for Individuals by More than Half,2011-06-08 16:47:00-04:00,ILMN,negative
660784.0,"Morgan Stanley Provides Color on Illumina, Overweight",2011-05-31 09:10:00-04:00,ILMN,negative
660785.0,Goldman Sachs PT Changes For 5/31,2011-05-31 07:59:00-04:00,ILMN,neutral
660786.0,Morgan Stanley Raises PT on Illumina To $84,2011-05-13 08:24:00-04:00,ILMN,neutral
660787.0,"Morgan Stanley Increases PT on Illumina to $84, Maintains Overweight (ILMN)",2011-05-13 08:09:00-04:00,ILMN,negative
660788.0,Piper Jaffray Comments On Illumina Following Solid Quarterly Results,2011-04-27 10:01:00-04:00,ILMN,positive
660789.0,Citigroup Raises PT On Illumina To $90,2011-04-27 07:59:00-04:00,ILMN,neutral
660790.0,J.P. Morgan Maintains Overweight on Illumina (ILMN),2011-04-27 07:28:00-04:00,ILMN,negative
660791.0,Piper Jaffray Raises PT On Illumina To $85,2011-04-27 06:59:00-04:00,ILMN,neutral
660792.0,Illumina Reports EPS of $0.35 vs. $0.31 Estimate; Revenues $282.5M vs. $261.41M Estimate,2011-04-26 16:25:00-04:00,ILMN,neutral
660793.0,"Stocks to watch For April 26: WU, NBR, AMZN, F, KO, HSY, VLO, LO, DV, MMM, LMT, BRCM…",2011-04-26 06:34:00-04:00,ILMN,neutral
660794.0,Wedbush Reaffirms Overweight On Illumina (ILMN),2011-04-25 08:41:00-04:00,ILMN,negative
660795.0,"Piper Jaffray Maintains Rating, Ups PT On Illumina To $79",2011-04-08 07:26:00-04:00,ILMN,neutral
660796.0,Piper Jaffray Raises PT On Illumina To $79,2011-04-08 06:53:00-04:00,ILMN,neutral
660797.0,"Goldman Sachs Comments On Illumina, Updates Its Model",2011-04-05 09:38:00-04:00,ILMN,neutral
660798.0,Piper Jaffray Updates On ILMN,2011-04-04 08:50:00-04:00,ILMN,neutral
660799.0,"Critical Stock Alerts: Insider Trade for Cisco, Yahoo, Netflix, Gap, Illumina, & Priceline.com ",2011-03-28 09:31:00-04:00,ILMN,negative
660800.0,"Benzinga's Top Upgrades (NOK, ILMN, NVDA, T)",2011-03-28 08:21:00-04:00,ILMN,positive
660801.0,UPDATE: Auriga Color On ILMN Upgrade,2011-03-28 08:10:00-04:00,ILMN,neutral
660802.0,"Auriga Upgrades Illumina To Buy, $75 PT",2011-03-28 07:23:00-04:00,ILMN,neutral
660803.0,Wedbush Maintains ILMN Outperform Rating,2011-03-21 07:32:00-04:00,ILMN,neutral
660804.0,Illumina Closes $800 Million Convertible Senior Notes   ,2011-03-18 16:02:00-04:00,ILMN,neutral
660805.0,"Oppenheimer Assumes Coverage Of LIFE, ILMN",2011-03-16 16:27:00-04:00,ILMN,neutral
660806.0,Deutsche Bank Maintains ILMN's Buy Rating,2011-03-15 08:36:00-04:00,ILMN,neutral
660807.0,Illumina to Offer $800 Million Convertible Senior Notes; Expects to Use up to $425M to Repurchase Shares   ,2011-03-14 16:10:00-04:00,ILMN,positive
660808.0,ILMN $800M In Convertible Senior Notes (ILMN),2011-03-14 16:07:00-04:00,ILMN,neutral
660809.0,Health Insurers Triple S&P 500 Returns,2011-03-10 12:21:00-05:00,ILMN,neutral
660810.0,"Top 4 Mid-Cap Stocks In The Biotechnology Industry With The Highest Operating Margin (TECH, CEPH, ILMN, TLCR)",2011-02-18 03:08:00-05:00,ILMN,positive
660811.0,President Obama's FY2012 Budget Details Released,2011-02-14 09:21:00-05:00,ILMN,neutral
660812.0,"Citigroup Comments On NIH Budget And F2011 Appropriations (LIFE, ILMN)",2011-02-14 07:30:00-05:00,ILMN,neutral
660813.0,"ILMN 4Q2010 In-Line With Preannouncement, Goldman Sachs Reports",2011-02-09 09:27:00-05:00,ILMN,neutral
660814.0,Piper Jaffray Reiterates Its OW Rating On Illumina & Raises Its PT To $76,2011-02-09 09:09:00-05:00,ILMN,neutral
660815.0,"Benzinga's Top Downgrades (ILMN, SWIR, MOTR, USNA)",2011-02-09 08:22:00-05:00,ILMN,positive
660816.0,Piper Jaffray Raises PT On Illumina To $76,2011-02-09 07:50:00-05:00,ILMN,neutral
660817.0,J.P. Morgan Raises Illumina Price Target To $75 (ILMN),2011-02-09 07:41:00-05:00,ILMN,neutral
660818.0,JP Morgan Raises PT On Illumina To $75,2011-02-09 07:22:00-05:00,ILMN,positive
660819.0,Illumina Reports Q4 EPS of $.29 vs. $.29,2011-02-08 16:28:00-05:00,ILMN,neutral
660820.0,Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2010: EPS of $0.25,2011-02-08 16:10:00-05:00,ILMN,neutral
660821.0,Piper Jaffray Provides Color On ILMN Leukemia Tumor Data,2011-02-07 08:19:00-05:00,ILMN,negative
660822.0,"Affymetrix Net Soars, Sales Dip  - Analyst Blog",2011-02-03 10:07:00-05:00,ILMN,neutral
660823.0,"Affymetrix Net Soars, Sales Dip  - Analyst Blog",2011-02-03 09:45:00-05:00,ILMN,neutral
660824.0,Piper Jaffray Maintains Illumina Overweight Rating (ILMN),2011-02-03 08:49:00-05:00,ILMN,negative
660825.0,Piper Jaffray Maintains Illumina Overweight Rating (ILMN),2011-02-03 08:49:00-05:00,ILMN,negative
660826.0,Citigroup Ups ILMN To Buy,2011-01-20 07:02:00-05:00,ILMN,neutral
660827.0,Citigroup Raises PT On Illumina,2011-01-20 06:49:00-05:00,ILMN,neutral
660828.0,Affymetrix's Rice Genotyping Test - Analyst Blog,2011-01-18 18:01:00-05:00,ILMN,neutral
660829.0,Affymetrix's Rice Genotyping Test - Analyst Blog,2011-01-18 17:37:00-05:00,ILMN,neutral
660830.0,"Affymetrix Posts 4Q View, Inks Deal - Analyst Blog",2011-01-14 13:01:00-05:00,ILMN,negative
660831.0,"Affymetrix Posts 4Q View, Inks Deal - Analyst Blog",2011-01-14 12:15:00-05:00,ILMN,negative
660832.0,Illumina Illuminates Results - Analyst Blog,2011-01-12 18:31:00-05:00,ILMN,neutral
660833.0,Illumina Illuminates Results - Analyst Blog,2011-01-12 17:55:00-05:00,ILMN,neutral
660834.0,Piper Jaffray Reiterates Overweight Rating on Sequenom (SQNM),2011-01-12 13:36:00-05:00,ILMN,negative
660835.0,Auriga Reiterates Buy Rating on Illumina Inc. (ILMN),2011-01-12 13:31:00-05:00,ILMN,neutral
660836.0,Goldman Sachs Comments On Illumina & Reiterates Its Buy Rating,2011-01-12 10:31:00-05:00,ILMN,neutral
660837.0,"Benzinga's Top Pre-Market NASDAQ Losers (ILMN, SNDK, VOD, RYAAY)",2011-01-12 08:43:00-05:00,ILMN,negative
660838.0,"Piper Jaffray Overweight On Illumina, Inc.  (ILMN)",2011-01-12 07:35:00-05:00,ILMN,negative
660839.0,Morgan Stanley Raises ILMN Target To $78,2011-01-06 10:48:00-05:00,ILMN,neutral
660840.0,"J.P. Morgan Raises Target On Illumina, Inc.  (ILMN)",2011-01-04 07:25:00-05:00,ILMN,neutral
660841.0,"Puts Purchased on Illumina, Inc. (ILMN)",2010-12-15 10:37:00-05:00,ILMN,neutral
660842.0,Auriga Sees Strong Upside In Illumina ,2010-12-09 08:33:00-05:00,ILMN,positive
660843.0,Illumina Inc (ILMN) Maintains Buy Rating,2010-11-09 07:54:00-05:00,ILMN,neutral
660844.0,"Market Roundup (MOT, LOJN, GTXI, AMLN, ILMN, FFIV)",2010-10-27 13:15:00-04:00,ILMN,neutral
660845.0,"3 Stocks To Consider (TEO, NTGR, ILMN)",2010-10-27 11:54:00-04:00,ILMN,neutral
660846.0,Illumina Announces Solid 3Q Earnings; Shares Rise,2010-10-27 08:15:00-04:00,ILMN,positive
660847.0,Illumina Reports Financial Results for Third Quarter; EPS $.30,2010-10-26 16:15:00-04:00,ILMN,neutral
660848.0,Oppenheimer Expects Another Strong Quarter From Illumina,2010-10-25 08:25:00-04:00,ILMN,positive
660849.0,Options Traders Still Bullish on Illumina (ILMN),2010-10-12 12:34:00-04:00,ILMN,neutral
660850.0,"TSL, YGE, WAT, LIFE, ILMN Initiated At Outperform",2010-10-08 10:12:00-04:00,ILMN,neutral
660851.0,Covaris Signs Co-Marketing Agreement with Illumina (ILMN),2010-09-28 07:27:00-04:00,ILMN,positive
660852.0,"Genetic Gains? Affymetrix and Illumina (AFFX, ILMN)",2010-09-21 11:36:00-04:00,ILMN,positive
660853.0,Downside Purchased on Illumina (ILMN),2010-09-10 12:19:00-04:00,ILMN,negative
660854.0,"Stocks Hitting 52-Week Highs (ATML, ENTR, ILMN, SOLR)",2010-08-05 12:20:00-04:00,ILMN,neutral
660855.0,J.P. Morgan Reiterates Overweight Rating On Illumina (ILMN),2010-07-28 12:27:00-04:00,ILMN,negative
660856.0,Illumina Soars On Upbeat Q2 Results,2010-07-28 10:12:00-04:00,ILMN,neutral
660857.0,ILMN’s Quarter Results Show That Array Consumables Are Back With A Bang ,2010-07-28 10:09:00-04:00,ILMN,neutral
660858.0,"Benzinga’s Top Pre-Market NASDAQ Gainers (BWLD, CHRW, ILMN, AONE)",2010-07-28 08:36:00-04:00,ILMN,positive
660859.0,Illumina Beats; Shares Pop (ILMN),2010-07-27 17:17:00-04:00,ILMN,positive
660860.0,"Deutsche Bank: Muted Recovery, Fx Headwinds Causing Uncertainties In Life Sciences Tools Sector",2010-07-13 10:48:00-04:00,ILMN,negative
660861.0,I Love This Game  07-07-2010,2010-07-07 18:23:00-04:00,ILMN,positive
660862.0,Calls Purchased on Illumina Inc. (ILMN),2010-07-07 15:11:00-04:00,ILMN,neutral
660863.0,Citigroup Initiates Hold Rating on Illumina Inc. (ILMN),2010-06-30 09:40:00-04:00,ILMN,neutral
660864.0,Puts Sold on Illumina (ILMN),2010-06-02 12:58:00-04:00,ILMN,neutral
660865.0,Illumina Sees Bullish Options Trade,2010-05-14 11:03:00-04:00,ILMN,neutral
660866.0,"Benzinga’s Volume Movers (IRBT, ILMN, CPNO, LOGM, JST)",2010-04-29 15:37:00-04:00,ILMN,neutral
660867.0,"Deutsche Bank Market Update (ROK, ITRI, ORLY, ILMN)",2010-04-29 12:06:00-04:00,ILMN,neutral
660868.0,How Will Obama-Care Play Into The Markets And ETFs?,2010-03-21 21:50:00-04:00,ILMN,positive
660869.0,Illumina Inc. (ILMN) Gets An Equal-Weight Rating,2010-01-19 10:06:00-05:00,ILMN,neutral
660870.0,"Benzinga’s Volume Movers (XRTX, ASYS, BIDU, FMBI, ILMN)",2010-01-13 13:46:00-05:00,ILMN,neutral
660871.0,Tuesday's Breakout Stocks: Pumping up Your Portfolio with NBTY,2010-01-13 08:12:00-05:00,ILMN,neutral
660872.0,"Top 5 Mid-Cap Stocks With The Highest 50-Day Moving Average (ILMN, NYT, LEN, X, GCI)",2010-01-13 06:20:00-05:00,ILMN,positive
660873.0,"Benzinga's Volume Movers (APWR, HAYN, BCSI, NUVA)",2009-11-25 14:12:00-05:00,ILMN,neutral
660874.0,"Benzinga's Volume Movers (PEET, CBRL, GPRE, NUAN)",2009-11-24 14:05:00-05:00,ILMN,neutral
660875.0,"Benzinga’s Biggest Losers (BZ, ADSK, ILMN, CRM, NANO, ONCY)",2009-11-18 10:51:00-05:00,ILMN,negative
660876.0,Illumina Inc. (ILMN) ripe for further correction,2009-10-28 23:30:00-04:00,ILMN,neutral
660877.0,"Pre-Market Losers (APOL, SAP, ILMN, SPW, FISV)",2009-10-28 09:36:00-04:00,ILMN,negative
660878.0,"Earnings Round Up (WSII, APOL, ELMN, QTM, AMKR, ETFC)",2009-10-28 05:58:00-04:00,ILMN,neutral
660879.0,"RothmanResearch.com Stock Review for CHRW, AGNC, ESLR, HSTX, ILMN and FNFG",2009-08-13 07:16:00-04:00,ILMN,neutral
